|
特拉華州
|
| |
13-1840497
|
|
|
(州或其他司法管轄區
成立公司或組織) |
| |
(税務局僱主
標識號) |
|
|
Glenpointe Center East,3樓
弗蘭克·W·伯爾大道300號,21號套房 新澤西州蒂內克 |
| |
07666-6712 |
|
|
(主要執行辦公室地址)
|
| |
(郵政編碼)
|
|
|
每個班級的標題
|
| |
交易代碼
|
| |
註冊的每個交易所的名稱
|
|
|
A類普通股,0.0001美元
每股面值 |
| |
PAHC
|
| |
納斯達克股票市場
|
|
|
大型加速文件服務器
☐
|
| |
加速文件管理器
|
|
|
非加速文件管理器
☐
|
| |
較小的報告公司
☐
|
|
|
新興成長型公司
☐
|
| | | |
| | |
第
頁
|
| |||
前瞻性陳述
|
| | | | 3 | | |
市場排名等行業數據
|
| | | | 4 | | |
商標、服務標記和商品名稱
|
| | | | 5 | | |
第一部分 | | | | | | | |
第1項。
業務
|
| | | | 6 | | |
第1A項。
風險因素
|
| | | | 28 | | |
項目1B。
未解決的員工意見
|
| | | | 54 | | |
第2項。
屬性
|
| | | | 54 | | |
第3項。
法律訴訟
|
| | | | 54 | | |
第4項。
煤礦安全信息披露
|
| | | | 55 | | |
第二部分 | | | | | | | |
第5項。
註冊人普通股、相關股東事項和發行人購買股權證券的市場
|
| | | | 56 | | |
第6項。
選定的財務數據
|
| | | | 57 | | |
第7項。
管理層對財務狀況和經營成果的討論和分析
|
| | | | 60 | | |
項目7A。
關於市場風險的定量和定性披露
|
| | | | 81 | | |
第8項。
財務報表及輔助數據
|
| | | | 83 | | |
第9項。
會計在會計和財務披露方面的變更和分歧
|
| | | | 123 | | |
第9A項。
控制程序
|
| | | | 123 | | |
第9B項。
其他信息
|
| | | | 125 | | |
第三部分 | | | | | | | |
第10項。
董事、高管和公司治理
|
| | | | 126 | | |
物品編號11。
高管薪酬
|
| | | | 126 | | |
第12項。
某些受益所有者的擔保所有權以及管理層和相關股東事宜
|
| | | | 126 | | |
第13項。
某些關係和相關交易,以及董事獨立性
|
| | | | 126 | | |
第14項。
主要會計費和服務
|
| | | | 126 | | |
第四部分 | | | | | | | |
物品:15。
展品,財務報表明細表
|
| | | | 127 | | |
簽名
|
| | | | 131 | | |
| | |
細分市場
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 527 | | | | | $ | 532 | | | | | $ | 532 | | | | | $ | (5) | | | | |
|
(1)%
|
| | | | $ | 0 | | | | |
|
0%
|
| | | |
|
66%
|
| | | |
|
64%
|
| | | |
|
65%
|
| |
礦物質營養
|
| | | | 214 | | | | | | 234 | | | | | | 235 | | | | | | (19) | | | | | | (8)% | | | | | | (1) | | | | |
|
(0)%
|
| | | |
|
27%
|
| | | |
|
28%
|
| | | |
|
29%
|
| |
性能產品
|
| | | | 59 | | | | | | 62 | | | | | | 53 | | | | | | (3) | | | | |
|
(5)%
|
| | | | | 9 | | | | |
|
17%
|
| | | |
|
7%
|
| | | |
|
8%
|
| | | |
|
7%
|
| |
合計
|
| | | $ | 800 | | | | | $ | 828 | | | | | $ | 820 | | | | | $ | (28) | | | | |
|
(3)%
|
| | | | $ | 8 | | | | |
|
1%
|
| | | | | | | | | | | | | | | | | | | |
|
| | |
種
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
家禽
|
| | | $ | 301 | | | | | $ | 316 | | | | | $ | 321 | | | | | $ | (15) | | | | |
|
(5)%
|
| | | | $ | (5) | | | | |
|
(2)%
|
| | | |
|
38%
|
| | | |
|
38%
|
| | | |
|
39%
|
| |
奶製品
|
| | | | 163 | | | | | | 170 | | | | | | 177 | | | | | | (7) | | | | |
|
(4)%
|
| | | | | (7) | | | | |
|
(4)%
|
| | | |
|
20%
|
| | | |
|
21%
|
| | | |
|
22%
|
| |
頭牛
|
| | | | 94 | | | | | | 88 | | | | | | 80 | | | | | | 6 | | | | |
|
7%
|
| | | | | 8 | | | | |
|
10%
|
| | | |
|
12%
|
| | | |
|
11%
|
| | | |
|
10%
|
| |
豬
|
| | | | 81 | | | | | | 101 | | | | | | 100 | | | | | | (20) | | | | |
|
(20)%
|
| | | | | 1 | | | | |
|
1%
|
| | | |
|
10%
|
| | | |
|
12%
|
| | | |
|
12%
|
| |
其他(1) | | | | | 161 | | | | | | 153 | | | | | | 142 | | | | | | 8 | | | | |
|
5%
|
| | | | | 11 | | | | |
|
8%
|
| | | |
|
20%
|
| | | |
|
18%
|
| | | |
|
17%
|
| |
合計
|
| | | $ | 800 | | | | | $ | 828 | | | | | $ | 820 | | | | | $ | (28) | | | | |
|
(3)%
|
| | | | $ | 8 | | | | |
|
1%
|
| | | | | | | | | | | | | | | | | | | |
|
| | |
地區(2)
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
美國
|
| | | $ | 472 | | | | | $ | 481 | | | | | $ | 491 | | | | | $ | (9) | | | | |
|
(2)%
|
| | | | $ | (10) | | | | |
|
(2)%
|
| | | |
|
59%
|
| | | |
|
58%
|
| | | |
|
60%
|
| |
拉丁美洲和加拿大
|
| | | | 159 | | | | | | 152 | | | | | | 143 | | | | | | 7 | | | | |
|
5%
|
| | | | | 9 | | | | |
|
6%
|
| | | |
|
20%
|
| | | |
|
18%
|
| | | |
|
17%
|
| |
歐洲、中東和非洲
|
| | | | 112 | | | | | | 105 | | | | | | 110 | | | | | | 7 | | | | |
|
7%
|
| | | | | (5) | | | | |
|
(5)%
|
| | | |
|
14%
|
| | | |
|
13%
|
| | | |
|
13%
|
| |
亞太地區
|
| | | | 57 | | | | | | 90 | | | | | | 76 | | | | | | (33) | | | | |
|
(37)%
|
| | | | | 14 | | | | |
|
18%
|
| | | |
|
7%
|
| | | |
|
11%
|
| | | |
|
9%
|
| |
合計
|
| | | $ | 800 | | | | | $ | 828 | | | | | $ | 820 | | | | | $ | (28) | | | | |
|
(3)%
|
| | | | $ | 8 | | | | |
|
1%
|
| | | | | | | | | | | | | | | | | | | |
| | |
調整後EBITDA(1)
|
| |
更改
|
| |
佔總數(2)的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 123 | | | | | $ | 136 | | | | | $ | 142 | | | | | $ | (13) | | | | |
|
(10)%
|
| | | | $ | (6) | | | | |
|
(4)%
|
| | | |
|
87%
|
| | | |
|
87%
|
| | | |
|
87%
|
| |
礦物質營養
|
| | | | 15 | | | | | | 16 | | | | | | 19 | | | | | | (1) | | | | |
|
(7)%
|
| | | | | (3) | | | | |
|
(15)%
|
| | | |
|
10%
|
| | | |
|
10%
|
| | | |
|
11%
|
| |
性能產品
|
| | | | 5 | | | | | | 5 | | | | | | 2 | | | | | | (0) | | | | |
|
(4)%
|
| | | | | 3 | | | | |
|
151%
|
| | | |
|
3%
|
| | | |
|
3%
|
| | | |
|
1%
|
| |
企業
|
| | | | (40) | | | | | | (38) | | | | | | (33) | | | | | | (2) | | | | |
|
*
|
| | | | | (5) | | | | |
|
*
|
| | | | | | | | | | | | | | | | | | | |
合計
|
| | | $ | 102 | | | | | $ | 118 | | | | | $ | 129 | | | | | $ | (16) | | | | |
|
(13)%
|
| | | | $ | (11) | | | | |
|
(8)%
|
| | | | | | | | | | | | | | | | | | | |
| | |
可確認淨資產
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
動物健康
|
| | | $ | 561 | | | | | $ | 509 | | | | | $ | 456 | | | | | $ | 52 | | | | |
|
10%
|
| | | | $ | 53 | | | | |
|
12%
|
| | | |
|
71%
|
| | | |
|
70%
|
| | | |
|
68%
|
| |
礦物質營養
|
| | | | 66 | | | | | | 68 | | | | | | 70 | | | | | | (2) | | | | |
|
(2)%
|
| | | | | (2) | | | | |
|
(3)%
|
| | | |
|
8%
|
| | | |
|
9%
|
| | | |
|
10%
|
| |
性能產品
|
| | | | 31 | | | | | | 33 | | | | | | 24 | | | | | | (2) | | | | |
|
(6)%
|
| | | | | 9 | | | | |
|
37%
|
| | | |
|
4%
|
| | | |
|
5%
|
| | | |
|
4%
|
| |
企業
|
| | | | 127 | | | | | | 117 | | | | | | 122 | | | | | | 10 | | | | |
|
8%
|
| | | | | (5) | | | | |
|
(4)%
|
| | | |
|
16%
|
| | | |
|
16%
|
| | | |
|
18%
|
| |
合計
|
| | | $ | 784 | | | | | $ | 727 | | | | | $ | 672 | | | | | $ | 58 | | | | |
|
8%
|
| | | | $ | 54 | | | | |
|
8%
|
| | | | | | | | | | | | | | | | | | | |
| | |
產品組
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
MFA和其他
|
| | | $ | 322 | | | | | $ | 350 | | | | | $ | 337 | | | | | $ | (28) | | | | |
|
(8)%
|
| | | | $ | 13 | | | | |
|
4%
|
| | | |
|
61%
|
| | | |
|
66%
|
| | | |
|
63%
|
| |
營養特產
|
| | | | 129 | | | | | | 113 | | | | | | 123 | | | | | | 16 | | | | |
|
14%
|
| | | | | (10) | | | | |
|
(8)%
|
| | | |
|
25%
|
| | | |
|
21%
|
| | | |
|
23%
|
| |
疫苗
|
| | | | 75 | | | | | | 68 | | | | | | 72 | | | | | | 7 | | | | |
|
10%
|
| | | | | (4) | | | | |
|
(5)%
|
| | | |
|
14%
|
| | | |
|
13%
|
| | | |
|
14%
|
| |
動物健康
|
| | | $ | 527 | | | | | $ | 532 | | | | | $ | 532 | | | | | $ | (5) | | | | |
|
(1)%
|
| | | | $ | (0) | | | | |
|
(0)%
|
| | | | | | | | | | | | | | | | | | | |
|
| | |
地區(1)
|
| |
更改
|
| |
佔總數的百分比
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
截至6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |
2020
|
| |
2019
|
| |
2018
|
| ||||||||||||||||||||||||||||||||||||
| | | | | | | | |
(百萬美元)
|
| | | | | | | | | | | | | | | | | | | |||||||||||||||||||||||||||||||||
美國
|
| | | $ | 214 | | | | | $ | 199 | | | | | $ | 220 | | | | | $ | 15 | | | | |
|
8%
|
| | | | $ | (21) | | | | |
|
(10)%
|
| | | |
|
41%
|
| | | |
|
37%
|
| | | |
|
41%
|
| |
拉丁美洲和加拿大
|
| | | | 148 | | | | | | 142 | | | | | | 129 | | | | | | 6 | | | | |
|
4%
|
| | | | | 13 | | | | |
|
10%
|
| | | |
|
28%
|
| | | |
|
27%
|
| | | |
|
24%
|
| |
歐洲、中東和非洲
|
| | | | 109 | | | | | | 103 | | | | | | 108 | | | | | | 6 | | | | |
|
6%
|
| | | | | (5) | | | | |
|
(5)%
|
| | | |
|
21%
|
| | | |
|
19%
|
| | | |
|
20%
|
| |
亞太地區
|
| | | | 56 | | | | | | 88 | | | | | | 75 | | | | | | (32) | | | | |
|
(36)%
|
| | | | | 13 | | | | |
|
17%
|
| | | |
|
11%
|
| | | |
|
17%
|
| | | |
|
14%
|
| |
合計
|
| | | $ | 527 | | | | | $ | 532 | | | | | $ | 532 | | | | | $ | (5) | | | | |
|
(1)%
|
| | | | $ | — | | | | |
|
0%
|
| | | | | | | | | | | | | | | | | | | |
產品
|
| |
活性成分
|
| |
的市場準入
活性成分 |
| |
説明
|
|
土黴素®/TM-50®/TM-100™ | | | 土黴素 | | |
1951
|
| | 多種用途的抗菌劑 | |
尼加拉瓜® | | | 尼加拉瓜巴津 | | |
1954
|
| | 家禽抗球蟲藥 | |
氨丙胺 | | | 氨丙胺 | | |
1960
|
| | 家禽和牛的抗球蟲藥 | |
Bloat Guard® | | | 聚二氫呋喃 | | |
1967
|
| | 牛的防脹治療 | |
Banminth® | | | 酒石酸吡喃酮 | | |
1972
|
| | 牲畜驅蟲劑 | |
Mecadox® | | | 卡巴多 | | |
1972
|
| | 豬腸道病原體,包括沙門氏菌病和痢疾的抗菌藥物 | |
斯塔法克®/埃斯卡林™/V-MAX® | | | 維吉尼亞黴素 | | |
1975
|
| | 用於預防和控制家禽、豬和牛疾病的抗菌劑 | |
Coxistac™/Posistac™ | | | 鹽黴素 | | |
1979
|
| |
家禽、牛和豬的抗球蟲藥
|
|
Rumatel® | | | 酒石酸莫蘭特 | | |
1981
|
| | 牲畜驅蟲劑 | |
Cerditac™/CerdiMix™ | | | 奧苯達唑 | | |
1982
|
| | 牲畜驅蟲劑 | |
Aviax® | | | 阿米達黴素 | | |
1995
|
| | 家禽抗球蟲藥 | |
新土黴素®/ NEO-TM™ |
| | 土黴素+新黴素 | | |
1999
|
| | 多種用途的兩種抗菌藥組合 | |
Aviax®Plus/Avi-Carb® | | | 阿米達黴素+尼加拉瓜巴嗪 | | |
2010
|
| | 家禽抗球蟲藥 | |
產品
|
| |
市場
條目 |
| |
説明
|
|
AB20® | | |
1989
|
| | 提高整體飼料質量的天然流動劑 | |
產品
|
| |
市場
條目 |
| |
説明
|
|
動畫® | | |
1999
|
| | 在關鍵過渡期保持奶牛適當的血鈣水平 | |
OmniGen® | | |
2004
|
| |
優化奶牛免疫功能,提高生產效率
|
|
Provia 6086™ | | |
2013
|
| | 各類家畜直接飼餵微生物(凝乳桿菌) | |
Magni-Phi® | | |
2015
|
| | 有助於改善腸道健康和免疫反應的專利混合物,這可能會提高家禽對營養的吸收和利用 | |
蜂窩狀酵母解決方案® | | |
2017
|
| | 各類家畜專用酵母培養產品,幫助改善消化健康 | |
Provia Prime™ | | |
2019
|
| | 四聯直飼微生物優化家禽腸道健康 | |
產品
|
| |
市場
條目 |
| |
説明
|
|
V.H.® | | |
1974
|
| | 預防家禽新城疫的活疫苗 | |
特製疫苗 | | |
1982
|
| | 針對家禽、豬和牛的細菌性或病毒性疾病的自體疫苗 | |
MVP輔助劑® | | |
1982
|
| | 增強疫苗免疫應答的獸用疫苗成分 | |
TAbic®M.B. | | |
2004
|
| | 預防家禽傳染性法氏囊病的活疫苗 | |
MJPRRS® | | |
2007
|
| | 預防豬繁殖與呼吸綜合徵(PRRS)的自體疫苗 | |
TAbic®IB VAR | | |
2009
|
| | 預防家禽傳染性支氣管炎變異株1 233A株的活疫苗 | |
TAbic®IB VAR206 | | |
2010
|
| | 預防雞傳染性支氣管炎206變異株的活疫苗 | |
MB-1TM | | |
2017
|
| | 預防家禽傳染性法氏囊病的孵化活疫苗 | |
Phi-TechTM | | |
2019
|
| | 便攜式電子注射設備和軟件,可正確交付疫苗和管理信息 | |
個業務部門
|
| |
位置
|
| |
擁有/
租賃 |
| |
近似。平方
素材 |
| |
目的
|
| |||
動物健康 | | | 以色列拜特謝梅什 | | |
擁有/
土地租賃 |
| | | | 78,000 | | | | 製造與研究 | |
動物健康 | | | 巴西布拉甘卡·保利斯塔 | | | 擁有 | | | | | 50,000 | | | | 製造和管理 | |
動物健康 | | | 阿根廷布宜諾斯艾利斯 | | | 擁有 | | | | | 43,000 | | | | 製造和管理 | |
動物健康 | | | 伊利諾伊州Chillicothe市 | | | 擁有 | | | | | 19,000 | | | | 製造 | |
動物健康 | | | 俄勒岡州科瓦利斯 | | | 擁有 | | | | | 5,000 | | | | 調研 | |
動物健康 | | | 巴西瓜魯霍斯 | | | 擁有 | | | | | 1,294,000 | | | |
製造、銷售、預混、
研究和管理 |
|
動物健康 | | | Neot Hovav,以色列 | | |
擁有/ 土地契約 |
| | | | 140,000 | | | | 製造與研究 | |
礦物質營養 | | | 內布拉斯加州奧馬哈 | | | 擁有 | | | | | 84,000 | | | | 製造 | |
動物健康 | | | 內布拉斯加州奧馬哈 | | | 擁有 | | | | | 43,000 | | | | 製造、銷售和研究 | |
動物健康 | | | 佩奇·提克瓦,以色列 | | | 擁有 | | | | | 60,000 | | | | 製造 | |
動物健康和礦物質營養 | | | 伊利諾伊州昆西 | | | 擁有 | | | | | 306,000 | | | | 製造、銷售、研究和管理 | |
性能產品
|
| | 加利福尼亞州聖達菲温泉 | | | 擁有 | | | | | 108,000 | | | | 製造 | |
動物健康 | | | 賓夕法尼亞州州立學院 | | | 擁有 | | | | | 13,000 | | | | 調研 | |
動物健康 | | | 明尼蘇達州聖保羅 | | | 租賃 | | | | | 5,000 | | | | 調研 | |
動物健康 | | | 佛羅裏達州薩拉索塔 | | | 租賃 | | | | | 93,000 | | | | 製造、銷售、研究和管理 | |
企業 | | | 新澤西州蒂內克 | | | 租賃 | | | | | 50,000 | | | | 公司和行政部門 | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |||||||||||||||
| | |
(千元,每股除外)
|
| |||||||||||||||||||||||||||
運營結果數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨銷售額
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | 764,281 | | | | | $ | 751,526 | | |
銷貨成本
|
| | | | 543,472 | | | | | | 563,371 | | | | | | 553,103 | | | | | | 516,038 | | | | | | 512,494 | | |
毛利
|
| | | | 256,882 | | | | | | 264,624 | | | | | | 266,879 | | | | | | 248,243 | | | | | | 239,032 | | |
銷售、一般和行政費用
|
| | | | 187,688 | | | | | | 181,398 | | | | | | 167,953 | | | | | | 150,309 | | | | | | 153,288 | | |
營業收入
|
| | | | 69,194 | | | | | | 83,226 | | | | | | 98,926 | | | | | | 97,934 | | | | | | 85,744 | | |
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | 16,592 | | |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | |
債務清償損失
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | |
所得税前收入
|
| | | | 55,512 | | | | | | 71,505 | | | | | | 88,070 | | | | | | 80,543 | | | | | | 76,761 | | |
所得税撥備(福利)
|
| | | | 21,960 | | | | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (5,967) | | |
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | 82,728 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.63 | | | | | $ | 2.11 | | |
稀釋
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | 1.61 | | | | | $ | 2.07 | | |
加權平均已發行普通股 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | | 40,454 | | | | | | 40,412 | | | | | | 40,181 | | | | | | 39,524 | | | | | | 39,254 | | |
稀釋
|
| | | | 40,504 | | | | | | 40,523 | | | | | | 40,385 | | | | | | 40,042 | | | | | | 39,962 | | |
每股股息
|
| | | $ | 0.48 | | | | | $ | 0.46 | | | | | $ | 0.40 | | | | | $ | 0.40 | | | | | $ | 0.40 | | |
其他財務數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
調整後EBITDA(1)
|
| | | $ | 102,140 | | | | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | 114,060 | | |
經營活動提供的現金(2)
|
| | | | 59,348 | | | | | | 47,169 | | | | | | 70,008 | | | | | | 98,385 | | | | | | 37,218 | | |
資本支出
|
| | | | 34,045 | | | | | | 29,891 | | | | | | 18,548 | | | | | | 20,880 | | | | | | 36,352 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
資產負債表數據 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
現金和現金等價物以及短期投資
|
| | | $ | 91,343 | | | | | $ | 81,573 | | | | | $ | 79,168 | | | | | $ | 56,083 | | | | | $ | 33,605 | | |
營運資金(3)
|
| | | | 222,006 | | | | | | 242,902 | | | | | | 205,651 | | | | | | 198,036 | | | | | | 203,356 | | |
總資產
|
| | | | 784,100 | | | | | | 726,671 | | | | | | 671,679 | | | | | | 623,397 | | | | | | 607,835 | | |
總債務(4)
|
| | | | 387,007 | | | | | | 326,175 | | | | | | 312,381 | | | | | | 313,141 | | | | | | 350,172 | | |
長期債務和其他負債
|
| | | | 438,658 | | | | | | 356,429 | | | | | | 343,504 | | | | | | 356,444 | | | | | | 408,578 | | |
股東權益總額
|
| | | | 188,204 | | | | | | 216,015 | | | | | | 184,954 | | | | | | 151,157 | | | | | | 90,480 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | 64,615 | | | | | $ | 82,728 | | |
加號: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | | | | | 14,906 | | | | | | 16,592 | | |
所得税撥備(福利)
|
| | | | 21,960 | | | | | | 16,792 | | | | | | 23,187 | | | | | | 15,928 | | | | | | (5,967) | | |
折舊攤銷
|
| | | | 32,341 | | | | | | 27,564 | | | | | | 26,943 | | | | | | 26,001 | | | | | | 23,452 | | |
EBITDA
|
| | | | 100,709 | | | | | | 110,845 | | | | | | 126,923 | | | | | | 121,450 | | | | | | 116,805 | | |
重組成本
|
| | | | 425 | | | | | | 6,281 | | | | | | — | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | — | | |
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | 1,671 | | | | | | — | | | | | | 2,566 | | |
與收購相關的應計薪酬
|
| | | | — | | | | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | 1,680 | | |
與收購相關的交易成本
|
| | | | 462 | | | | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | 618 | | |
與收購相關的其他,淨額
|
| | | | (2,821) | | | | | | — | | | | | | (468) | | | | | | (972) | | | | | | — | | |
其他
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | — | | | | | | — | | |
養老金結算費
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | |
債務清償損失
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | |
調整後的EBITDA
|
| | | $ | 102,140 | | | | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | 120,119 | | | | | $ | 114,060 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2017
|
| |
2016
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
EBITDA
|
| | | $ | 100,709 | | | | | $ | 110,845 | | | | | $ | 126,923 | | | | | $ | 121,450 | | | | | $ | 116,805 | | |
調整 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
重組成本
|
| | | | 425 | | | | | | 6,281 | | | | | | — | | | | | | — | | | | | | — | | |
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | — | | |
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | 1,671 | | | | | | — | | | | | | 2,566 | | |
與收購相關的應計薪酬
|
| | | | — | | | | | | — | | | | | | 1,152 | | | | | | 1,680 | | | | | | 1,680 | | |
與收購相關的交易成本
|
| | | | 462 | | | | | | 213 | | | | | | 400 | | | | | | 1,274 | | | | | | 618 | | |
與收購相關的其他,淨額
|
| | | | (2,821) | | | | | | — | | | | | | (468) | | | | | | (972) | | | | | | — | | |
其他
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | — | | | | | | — | | |
養老金結算費
|
| | | | — | | | | | | — | | | | | | — | | | | | | 1,702 | | | | | | — | | |
保險結算收益
|
| | | | — | | | | | | — | | | | | | — | | | | | | (7,500) | | | | | | — | | |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | (113) | | | | | | (7,609) | | |
債務清償損失
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,598 | | | | | | — | | |
已支付利息
|
| | | | (11,577) | | | | | | (12,250) | | | | | | (11,208) | | | | | | (14,600) | | | | | | (14,215) | | |
繳納所得税
|
| | | | (20,866) | | | | | | (16,215) | | | | | | (15,191) | | | | | | (14,762) | | | | | | (16,828) | | |
經營性資產、負債及其他項目變動
|
| | | | (10,349) | | | | | | (42,403) | | | | | | (32,551) | | | | | | 128 | | | | | | (45,799) | | |
保險結算提供的現金
|
| | | | — | | | | | | — | | | | | | — | | | | | | 7,500 | | | | | | — | | |
經營活動提供的淨現金
|
| | | $ | 59,348 | | | | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 98,385 | | | | | $ | 37,218 | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||||||||||||||
| | |
(千元,每股除外)
|
| |||||||||||||||||||||||||||||||||||||||
淨銷售額
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | (27,641) | | | | |
|
(3)%
|
| | | | $ | 8,013 | | | | |
|
1%
|
| |
毛利
|
| | | | 256,882 | | | | | | 264,624 | | | | | | 266,879 | | | | | | (7,742) | | | | |
|
(3)%
|
| | | | | (2,255) | | | | |
|
(1)%
|
| |
銷售、一般和行政費用
|
| | | | 187,688 | | | | | | 181,398 | | | | | | 167,953 | | | | | | 6,290 | | | | |
|
3%
|
| | | | | 13,445 | | | | |
|
8%
|
| |
營業收入
|
| | | | 69,194 | | | | | | 83,226 | | | | | | 98,926 | | | | | | (14,032) | | | | |
|
(17)%
|
| | | | | (15,700) | | | | |
|
(16)%
|
| |
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | | | | | 1,080 | | | | |
|
9%
|
| | | | | (134) | | | | |
|
(1)%
|
| |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | 881 | | | | |
|
*
|
| | | | | 999 | | | | |
|
*
|
| |
所得税前收入
|
| | | | 55,512 | | | | | | 71,505 | | | | | | 88,070 | | | | | | (15,993) | | | | |
|
(22)%
|
| | | | | (16,565) | | | | |
|
(19)%
|
| |
所得税撥備
|
| | | | 21,960 | | | | | | 16,792 | | | | | | 23,187 | | | | | | 5,168 | | | | |
|
31%
|
| | | | | (6,395) | | | | |
|
(28)%
|
| |
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | (21,161) | | | | |
|
(39)%
|
| | | | $ | (10,170) | | | | |
|
(16)%
|
| |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | (0.52) | | | | | | | | | | | $ | (0.26) | | | | | | | | |
稀釋
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | | | | $ | (0.52) | | | | | | | | | | | $ | (0.26) | | | | | | | | |
加權平均流通股數量
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | | 40,454 | | | | | | 40,412 | | | | | | 40,181 | | | | | | | | | | | | | | | | | | | | | | | | | | |
稀釋
|
| | | | 40,504 | | | | | | 40,523 | | | | | | 40,385 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||
| | |
(千元,每股除外)
|
| |||||||||||||||||||||||||||
淨銷售額比率 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
毛利
|
| | |
|
32.1%
|
| | | |
|
32.0%
|
| | | |
|
32.5%
|
| | | | | | | | | | | | | |
銷售、一般和行政費用
|
| | |
|
23.5%
|
| | | |
|
21.9%
|
| | | |
|
20.5%
|
| | | | | | | | | | | | | |
營業收入
|
| | |
|
8.6%
|
| | | |
|
10.1%
|
| | | |
|
12.1%
|
| | | | | | | | | | | | | |
所得税前收入
|
| | |
|
6.9%
|
| | | |
|
8.6%
|
| | | |
|
10.7%
|
| | | | | | | | | | | | | |
淨收入
|
| | |
|
4.2%
|
| | | |
|
6.6%
|
| | | |
|
7.9%
|
| | | | | | | | | | | | | |
實際税率
|
| | |
|
39.6%
|
| | | |
|
23.5%
|
| | | |
|
26.3%
|
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||||||||
淨銷售額 | | | | | | | | | |||||||||||||||||||||||||||||||||||
MFA和其他
|
| | | $ | 322,300 | | | | | $ | 350,468 | | | | | $ | 336,666 | | | | | $ | (28,168) | | | | |
|
(8)%
|
| | | | $ | 13,802 | | | | |
|
4%
|
| |
營養特產
|
| | | | 129,264 | | | | | | 113,215 | | | | | | 122,978 | | | | | | 16,049 | | | | |
|
14%
|
| | | | | (9,763) | | | | |
|
(8)%
|
| |
疫苗
|
| | | | 75,340 | | | | | | 68,291 | | | | | | 72,083 | | | | | | 7,049 | | | | |
|
10%
|
| | | | | (3,792) | | | | |
|
(5)%
|
| |
動物健康
|
| | | | 526,904 | | | | | | 531,974 | | | | | | 531,727 | | | | | | (5,070) | | | | |
|
(1)%
|
| | | | | 247 | | | | |
|
0%
|
| |
礦物質營養
|
| | | | 214,412 | | | | | | 233,782 | | | | | | 234,922 | | | | | | (19,370) | | | | |
|
(8)%
|
| | | | | (1,140) | | | | |
|
(0)%
|
| |
性能產品
|
| | | | 59,038 | | | | | | 62,239 | | | | | | 53,333 | | | | | | (3,201) | | | | |
|
(5)%
|
| | | | | 8,906 | | | | |
|
17%
|
| |
合計
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | | | | $ | (27,641) | | | | |
|
(3)%
|
| | | | $ | 8,013 | | | | |
|
1%
|
| |
|
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||||||||
調整後的EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |||||
動物健康
|
| | | $ | 123,106 | | | | | $ | 136,049 | | | | | $ | 141,914 | | | | | $ | (12,943) | | | | |
|
(10)%
|
| | | | $ | (5,865) | | | | |
|
(4)%
|
| |
礦物質營養
|
| | | | 14,678 | | | | | | 15,712 | | | | | | 18,583 | | | | | | (1,034) | | | | |
|
(7)%
|
| | | | | (2,871) | | | | |
|
(15)%
|
| |
性能產品
|
| | | | 4,534 | | | | | | 4,728 | | | | | | 1,881 | | | | | | (194) | | | | |
|
(4)%
|
| | | | | 2,847 | | | | |
|
151%
|
| |
企業
|
| | | | (40,178) | | | | | | (38,452) | | | | | | (33,420) | | | | | | (1,726) | | | | |
|
*
|
| | | | | (5,032) | | | | |
|
*
|
| |
合計
|
| | | $ | 102,140 | | | | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | (15,897) | | | | |
|
(13)%
|
| | | | $ | (10,921) | | | | |
|
(8)%
|
| |
調整後的EBITDA比率以細分淨銷售額
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | |
|
23.4%
|
| | | |
|
25.6%
|
| | | |
|
26.7%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
礦物質營養
|
| | |
|
6.8%
|
| | | |
|
6.7%
|
| | | |
|
7.9%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
性能產品
|
| | |
|
7.7%
|
| | | |
|
7.6%
|
| | | |
|
3.5%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
公司(1)
|
| | |
|
(5.0)%
|
| | | |
|
(4.6)%
|
| | | |
|
(4.1)%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
總計(1)
|
| | |
|
12.8%
|
| | | |
|
14.3%
|
| | | |
|
15.7%
|
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||||||||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020/ 2019
|
| |
2019 / 2018
|
| |||||||||||||||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||||||||||||||
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | | | | $ | (21,161) | | | | |
|
(39)%
|
| | | | $ | (10,170) | | | | |
|
(16)%
|
| |
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | | | | | 1,080 | | | | |
|
9%
|
| | | | | (134) | | | | |
|
(1)%
|
| |
所得税撥備
|
| | | | 21,960 | | | | | | 16,792 | | | | | | 23,187 | | | | | | 5,168 | | | | |
|
31%
|
| | | | | (6,395) | | | | |
|
(28)%
|
| |
折舊和
攤銷 |
| | | | 32,341 | | | | | | 27,564 | | | | | | 26,943 | | | | | | 4,777 | | | | |
|
17%
|
| | | | | 621 | | | | |
|
2%
|
| |
EBITDA
|
| | | | 100,709 | | | | | | 110,845 | | | | | | 126,923 | | | | | | (10,136) | | | | |
|
(9)%
|
| | | | | (16,078) | | | | |
|
(13)%
|
| |
重組成本
|
| | | | 425 | | | | | | 6,281 | | | | | | — | | | | | | (5,856) | | | | |
|
(93)%
|
| | | | | — | | | | |
|
*
|
| |
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | | | | | — | | | | |
|
0%
|
| | | | | 1,925 | | | | |
|
576%
|
| |
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | 1,671 | | | | | | 280 | | | | |
|
*
|
| | | | | (1,671) | | | | |
|
*
|
| |
與收購相關的應計薪酬
|
| | | | — | | | | | | — | | | | | | 1,152 | | | | | | — | | | | |
|
*
|
| | | | | (1,152) | | | | |
|
*
|
| |
與收購相關的交易成本
|
| | | | 462 | | | | | | 213 | | | | | | 400 | | | | | | 249 | | | | |
|
117%
|
| | | | | (187) | | | | |
|
(47)%
|
| |
與收購相關的其他,淨額
|
| | | | (2,821) | | | | | | — | | | | | | (468) | | | | | | (2,821) | | | | |
|
*
|
| | | | | 468 | | | | |
|
*
|
| |
其他,淨額
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | 1,506 | | | | |
|
*
|
| | | | | (1,506) | | | | |
|
*
|
| |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | 881 | | | | |
|
*
|
| | | | | 999 | | | | |
|
*
|
| |
調整後的EBITDA
|
| | | $ | 102,140 | | | | | $ | 118,037 | | | | | $ | 128,958 | | | | | $ | (15,897) | | | | |
|
(13)%
|
| | | | $ | (10,921) | | | | |
|
(8)%
|
| |
截至2019年6月30日的年度
|
| |
2019
|
| |
2018
|
| ||||||
| | |
(單位為千,不包括百分比)
|
| |||||||||
所得税撥備
|
| | | $ | 16,792 | | | | | $ | 23,187 | | |
實際所得税率
|
| | | | 23.5% | | | | | | 26.3% | | |
某些所得税項目 | | | | | | | | | | | | | |
受益於行使的員工股票期權
|
| | | $ | (310) | | | | | $ | (3,773) | | |
強制通行費
|
| | | | (360) | | | | | | 403 | | |
減少國內遞延税金資產
|
| | | | — | | | | | | 2,289 | | |
減少境外遞延税金資產
|
| | | | — | | | | | | 1,156 | | |
確認聯邦和外國税收抵免
|
| | | | (1,417) | | | | | | (565) | | |
從累計其他綜合收益中重新分類
|
| | | | — | | | | | | 527 | | |
釋放未確認的税收優惠
|
| | | | (1,271) | | | | | | (994) | | |
合計
|
| | | $ | (3,358) | | | | | $ | (957) | | |
所得税撥備,不包括某些項目
|
| | | $ | 20,150 | | | | | $ | 24,144 | | |
不包括某些項目的有效所得税税率
|
| | | | 28.2% | | | | | | 27.4% | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
現金提供人/(使用於): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
經營活動
|
| | | $ | 59,348 | | | | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 12,179 | | | | | $ | (22,839) | | |
投資活動
|
| | | | (120,390) | | | | | | (14,133) | | | | | | (84,612) | | | | | | (106,257) | | | | | | 70,479 | | |
融資活動
|
| | | | 40,936 | | | | | | (4,107) | | | | | | (11,775) | | | | | | 45,043 | | | | | | 7,668 | | |
匯率變動對現金和現金等價物的影響
|
| | | | (1,124) | | | | | | (524) | | | | | | (536) | | | | | | (600) | | | | | | 12 | | |
現金和現金等價物淨增加/(減少)
|
| | | $ | (21,230) | | | | | $ | 28,405 | | | | | $ | (26,915) | | | | | $ | (49,635) | | | | | $ | 55,320 | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||
| | | | | | | | |
(千)
|
| |||||||||||||||||||||
EBITDA
|
| | | $ | 100,709 | | | | | $ | 110,845 | | | | | $ | 126,923 | | | | | $ | (10,136) | | | | | $ | (16,078) | | |
調整 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
重組成本
|
| | | | 425 | | | | | | 6,281 | | | | | | — | | | | | | (5,856) | | | | | | 6,281 | | |
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | | | | | — | | | | | | 1,925 | | |
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | 1,671 | | | | | | 280 | | | | | | (1,671) | | |
與收購相關的應計薪酬
|
| | | | — | | | | | | — | | | | | | 1,152 | | | | | | — | | | | | | (1,152) | | |
與收購相關的交易成本
|
| | | | 462 | | | | | | 213 | | | | | | 400 | | | | | | 249 | | | | | | (187) | | |
與收購相關的其他,淨額
|
| | | | (2,821) | | | | | | — | | | | | | (468) | | | | | | (2,821) | | | | | | 468 | | |
其他,淨額
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | 1,506 | | | | | | (1,506) | | |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | | | | | 881 | | | | | | 999 | | |
已支付利息,淨額
|
| | | | (11,577) | | | | | | (12,250) | | | | | | (11,208) | | | | | | 673 | | | | | | (1,042) | | |
繳納所得税
|
| | | | (20,866) | | | | | | (16,215) | | | | | | (15,191) | | | | | | (4,651) | | | | | | (1,024) | | |
經營性資產、負債及其他項目變動
|
| | | | (10,349) | | | | | | (42,403) | | | | | | (32,551) | | | | | | 32,054 | | | | | | (9,852) | | |
經營活動提供的淨現金
|
| | | $ | 59,348 | | | | | $ | 47,169 | | | | | $ | 70,008 | | | | | $ | 12,179 | | | | | $ | (22,839) | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020 / 2019
|
| |
2019 / 2018
|
| |||||||||||||||
| | |
(千為單位,比率除外)
|
| |||||||||||||||||||||||||||
現金和現金等價物以及短期投資
|
| | | $ | 91,343 | | | | | $ | 81,573 | | | | | $ | 79,168 | | | | | $ | 9,770 | | | | | $ | 2,405 | | |
營運資金
|
| | | | 222,006 | | | | | | 242,902 | | | | | | 205,651 | | | | | | (20,896) | | | | | | 37,251 | | |
流動資產與流動負債比率
|
| | | | 2.6:1 | | | | | | 2.71:1 | | | | | | 2.57:1 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020/2019
|
| |
2019/2018
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
應收賬款 - 交易
|
| | | $ | 126,522 | | | | | $ | 159,022 | | | | | $ | 135,742 | | | | | $ | (32,500) | | | | | $ | 23,280 | | |
DSO
|
| | | | 61 | | | | | | 70 | | | | | | 58 | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
更改
|
| |||||||||
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |
2020/2019
|
| |
2019/2018
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
庫存
|
| | | $ | 196,659 | | | | | $ | 198,322 | | | | | $ | 178,170 | | | | | $ | (1,663) | | | | | $ | 20,152 | | |
| | |
年
|
| | | | | | | |||||||||||||||||||||
| | |
在1個內
|
| |
超過1到3個
|
| |
3到5歲以上
|
| |
超過5個
|
| |
合計
|
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
長期債務(含本期部分)
|
| | | $ | 18,750 | | | | | $ | 200,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 218,750 | | |
循環信貸安排
|
| | | | — | | | | | | 169,000 | | | | | | — | | | | | | — | | | | | | 169,000 | | |
利息支付
|
| | | | 10,726 | | | | | | 10,321 | | | | | | — | | | | | | — | | | | | | 21,047 | | |
租賃承諾額
|
| | | | 7,211 | | | | | | 8,942 | | | | | | 4,457 | | | | | | 6,869 | | | | | | 27,479 | | |
或有對價
|
| | | | — | | | | | | 4,840 | | | | | | — | | | | | | — | | | | | | 4,840 | | |
其他
|
| | | | 1,010 | | | | | | 1,822 | | | | | | 1,228 | | | | | | 1,123 | | | | | | 5,183 | | |
合同總義務
|
| | | $ | 37,697 | | | | | $ | 394,925 | | | | | $ | 5,685 | | | | | $ | 7,992 | | | | | $ | 446,299 | | |
| | |
季度
|
| |
年
|
| ||||||||||||||||||||||||
截至的期間
|
| |
09月30日
2019 |
| |
12月31日
2019 |
| |
3月31日
2020 |
| |
06月30日
2020 |
| |
06月30日
2020 |
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 75,034 | | | | | $ | 91,955 | | | | | $ | 82,670 | | | | | $ | 72,641 | | | | | $ | 322,300 | | |
營養特色菜
|
| | | | 30,433 | | | | | | 33,062 | | | | | | 34,636 | | | | | | 31,133 | | | | | | 129,264 | | |
疫苗
|
| | | | 16,383 | | | | | | 18,672 | | | | | | 21,668 | | | | | | 18,617 | | | | | | 75,340 | | |
動物健康
|
| | | $ | 121,850 | | | | | $ | 143,689 | | | | | $ | 138,974 | | | | | $ | 122,391 | | | | | $ | 526,904 | | |
| | |
季度
|
| |
年
|
| ||||||||||||||||||||||||
截至的期間
|
| |
09月30日
2019 |
| |
12月31日
2019 |
| |
3月31日
2020 |
| |
06月30日
2020 |
| |
06月30日
2020 |
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
礦物質營養
|
| | | | 52,649 | | | | | | 55,685 | | | | | | 56,200 | | | | | | 49,878 | | | | | | 214,412 | | |
性能產品
|
| | | | 15,221 | | | | | | 14,638 | | | | | | 15,565 | | | | | | 13,614 | | | | | | 59,038 | | |
總淨銷售額
|
| | | | 189,720 | | | | | | 214,012 | | | | | | 210,739 | | | | | | 185,883 | | | | | | 800,354 | | |
銷貨成本
|
| | | | 132,057 | | | | | | 144,908 | | | | | | 141,188 | | | | | | 125,319 | | | | | | 543,472 | | |
毛利
|
| | | | 57,663 | | | | | | 69,104 | | | | | | 69,551 | | | | | | 60,564 | | | | | | 256,882 | | |
銷售、一般和行政
費用 |
| | | | 47,516 | | | | | | 49,495 | | | | | | 48,232 | | | | | | 42,445 | | | | | | 187,688 | | |
營業收入
|
| | | | 10,147 | | | | | | 19,609 | | | | | | 21,319 | | | | | | 18,119 | | | | | | 69,194 | | |
利息費用淨額
|
| | | | 3,354 | | | | | | 3,432 | | | | | | 3,263 | | | | | | 2,807 | | | | | | 12,856 | | |
外幣(收益)虧損,淨額
|
| | | | 3,221 | | | | | | (718) | | | | | | (608) | | | | | | (1,069) | | | | | | 826 | | |
所得税前收入
|
| | | | 3,572 | | | | | | 16,895 | | | | | | 18,664 | | | | | | 16,381 | | | | | | 55,512 | | |
所得税撥備(福利)
|
| | | | 1,057 | | | | | | 5,001 | | | | | | 5,163 | | | | | | 10,739 | | | | | | 21,960 | | |
淨收入
|
| | | $ | 2,515 | | | | | $ | 11,894 | | | | | $ | 13,501 | | | | | $ | 5,642 | | | | | $ | 33,552 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.06 | | | | | $ | 0.29 | | | | | $ | 0.33 | | | | | $ | 0.14 | | | | | $ | 0.83 | | |
稀釋
|
| | | $ | 0.06 | | | | | $ | 0.29 | | | | | $ | 0.33 | | | | | $ | 0.14 | | | | | $ | 0.83 | | |
調整後的EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 25,061 | | | | | $ | 33,838 | | | | | $ | 34,635 | | | | | $ | 29,572 | | | | | $ | 123,106 | | |
礦物質營養
|
| | | | 3,475 | | | | | | 3,684 | | | | | | 4,055 | | | | | | 3,464 | | | | | | 14,678 | | |
性能產品
|
| | | | 852 | | | | | | 1,457 | | | | | | 1,506 | | | | | | 719 | | | | | | 4,534 | | |
企業
|
| | | | (9,728) | | | | | | (10,491) | | | | | | (10,064) | | | | | | (9,895) | | | | | | (40,178) | | |
調整後的EBITDA
|
| | | $ | 19,660 | | | | | $ | 28,488 | | | | | $ | 30,132 | | | | | $ | 23,860 | | | | | $ | 102,140 | | |
淨收入與調整後EBITDA的對賬
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 2,515 | | | | | $ | 11,894 | | | | | $ | 13,501 | | | | | $ | 5,642 | | | | | $ | 33,552 | | |
利息費用淨額
|
| | | | 3,354 | | | | | | 3,432 | | | | | | 3,263 | | | | | | 2,807 | | | | | | 12,856 | | |
所得税撥備(福利)
|
| | | | 1,057 | | | | | | 5,001 | | | | | | 5,163 | | | | | | 10,739 | | | | | | 21,960 | | |
折舊攤銷
|
| | | | 7,781 | | | | | | 8,148 | | | | | | 8,248 | | | | | | 8,164 | | | | | | 32,341 | | |
EBITDA
|
| | | | 14,707 | | | | | | 28,475 | | | | | | 30,175 | | | | | | 27,352 | | | | | | 100,709 | | |
重組成本
|
| | | | 425 | | | | | | — | | | | | | — | | | | | | — | | | | | | 425 | | |
股票薪酬
|
| | | | 565 | | | | | | 564 | | | | | | 565 | | | | | | 565 | | | | | | 2,259 | | |
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | — | | | | | | — | | | | | | 280 | | |
與收購相關的交易成本
|
| | | | 462 | | | | | | — | | | | | | — | | | | | | — | | | | | | 462 | | |
與收購相關的其他,淨額
|
| | | | — | | | | | | 167 | | | | | | — | | | | | | (2,988) | | | | | | (2,821) | | |
外幣(收益)虧損,淨額
|
| | | | 3,221 | | | | | | (718) | | | | | | (608) | | | | | | (1,069) | | | | | | 826 | | |
調整後的EBITDA
|
| | | $ | 19,660 | | | | | $ | 28,488 | | | | | $ | 30,132 | | | | | $ | 23,860 | | | | | $ | 102,140 | | |
|
| | |
季度
|
| |
年
|
| ||||||||||||||||||||||||
截至的期間
|
| |
09月30日
2018 |
| |
12月31日
2018 |
| |
3月31日
2019 |
| |
06月30日
2019 |
| |
06月30日
2019 |
| |||||||||||||||
| | |
(千)
|
| |||||||||||||||||||||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 87,004 | | | | | $ | 93,054 | | | | | $ | 84,095 | | | | | $ | 86,315 | | | | | $ | 350,468 | | |
營養特色菜
|
| | | | 26,970 | | | | | | 29,460 | | | | | | 28,227 | | | | | | 28,558 | | | | | | 113,215 | | |
疫苗
|
| | | | 17,215 | | | | | | 17,048 | | | | | | 16,867 | | | | | | 17,161 | | | | | | 68,291 | | |
動物健康
|
| | | $ | 131,189 | | | | | $ | 139,562 | | | | | $ | 129,189 | | | | | $ | 132,034 | | | | | $ | 531,974 | | |
礦物質營養
|
| | | | 54,838 | | | | | | 62,319 | | | | | | 60,653 | | | | | | 55,972 | | | | | | 233,782 | | |
性能產品
|
| | | | 14,126 | | | | | | 16,342 | | | | | | 15,894 | | | | | | 15,877 | | | | | | 62,239 | | |
總淨銷售額
|
| | | | 200,153 | | | | | | 218,223 | | | | | | 205,736 | | | | | | 203,883 | | | | | | 827,995 | | |
銷貨成本
|
| | | | 134,348 | | | | | | 149,579 | | | | | | 140,864 | | | | | | 138,580 | | | | | | 563,371 | | |
毛利
|
| | | | 65,805 | | | | | | 68,644 | | | | | | 64,872 | | | | | | 65,303 | | | | | | 264,624 | | |
銷售、一般和行政
費用 |
| | | | 42,952 | | | | | | 42,938 | | | | | | 42,304 | | | | | | 53,204 | | | | | | 181,398 | | |
營業收入
|
| | | | 22,853 | | | | | | 25,706 | | | | | | 22,568 | | | | | | 12,099 | | | | | | 83,226 | | |
利息費用淨額
|
| | | | 2,783 | | | | | | 3,015 | | | | | | 2,931 | | | | | | 3,047 | | | | | | 11,776 | | |
外幣(收益)虧損,淨額
|
| | | | (2,635) | | | | | | 2,617 | | | | | | 122 | | | | | | (159) | | | | | | (55) | | |
所得税前收入
|
| | | | 22,705 | | | | | | 20,074 | | | | | | 19,515 | | | | | | 9,211 | | | | | | 71,505 | | |
所得税撥備
|
| | | | 6,391 | | | | | | 5,326 | | | | | | 4,666 | | | | | | 409 | | | | | | 16,792 | | |
淨收入
|
| | | $ | 16,314 | | | | | $ | 14,748 | | | | | $ | 14,849 | | | | | $ | 8,802 | | | | | $ | 54,713 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.40 | | | | | $ | 0.37 | | | | | $ | 0.37 | | | | | $ | 0.22 | | | | | $ | 1.35 | | |
稀釋
|
| | | $ | 0.40 | | | | | $ | 0.36 | | | | | $ | 0.37 | | | | | $ | 0.22 | | | | | $ | 1.35 | | |
調整後的EBITDA | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 35,716 | | | | | $ | 35,925 | | | | | $ | 33,241 | | | | | $ | 31,167 | | | | | $ | 136,049 | | |
礦物質營養
|
| | | | 2,563 | | | | | | 4,084 | | | | | | 5,287 | | | | | | 3,778 | | | | | | 15,712 | | |
性能產品
|
| | | | 716 | | | | | | 1,514 | | | | | | 1,330 | | | | | | 1,168 | | | | | | 4,728 | | |
企業
|
| | | | (8,886) | | | | | | (9,918) | | | | | | (9,850) | | | | | | (9,798) | | | | | | (38,452) | | |
調整後的EBITDA
|
| | | $ | 30,109 | | | | | $ | 31,605 | | | | | $ | 30,008 | | | | | $ | 26,315 | | | | | $ | 118,037 | | |
淨收入與調整後EBITDA的對賬
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 16,314 | | | | | $ | 14,748 | | | | | $ | 14,849 | | | | | $ | 8,802 | | | | | $ | 54,713 | | |
利息費用淨額
|
| | | | 2,783 | | | | | | 3,015 | | | | | | 2,931 | | | | | | 3,047 | | | | | | 11,776 | | |
所得税撥備
|
| | | | 6,391 | | | | | | 5,326 | | | | | | 4,666 | | | | | | 409 | | | | | | 16,792 | | |
折舊攤銷
|
| | | | 6,691 | | | | | | 6,841 | | | | | | 6,875 | | | | | | 7,157 | | | | | | 27,564 | | |
EBITDA
|
| | | | 32,179 | | | | | | 29,930 | | | | | | 29,321 | | | | | | 19,415 | | | | | | 110,845 | | |
重組成本
|
| | | | — | | | | | | — | | | | | | — | | | | | | 6,281 | | | | | | 6,281 | | |
股票薪酬
|
| | | | 565 | | | | | | 564 | | | | | | 565 | | | | | | 565 | | | | | | 2,259 | | |
與收購相關的交易成本
|
| | | | — | | | | | | — | | | | | | — | | | | | | 213 | | | | | | 213 | | |
其他
|
| | | | — | | | | | | (1,506) | | | | | | — | | | | | | — | | | | | | (1,506) | | |
外幣(收益)虧損,淨額
|
| | | | (2,635) | | | | | | 2,617 | | | | | | 122 | | | | | | (159) | | | | | | (55) | | |
調整後的EBITDA
|
| | | $ | 30,109 | | | | | $ | 31,605 | | | | | $ | 30,008 | | | | | $ | 26,315 | | | | | $ | 118,037 | | |
|
|
獨立註冊會計師事務所報告
|
| | | | 84 | | |
|
截至2020年6月30日、2019年6月30日和2018年6月30日的財年合併經營報表
|
| | | | 86 | | |
|
截至2020年6月30日、2019年6月30日和2019年6月30日的財政年度合併全面收益表
2018 |
| | | | 87 | | |
|
截至2020年6月30日和2019年6月30日的合併資產負債表
|
| | | | 88 | | |
|
截至2020年6月30日、2019年6月30日和2018年6月30日的財政年度現金流量合併報表
|
| | | | 89 | | |
|
截至2020年6月30日的財年股東權益變動合併報表
2019年和2018年。 |
| | | | 90 | | |
|
截至2020年6月30日、2019年6月30日和2019年6月30日的財政年度合併財務報表附註
2018 |
| | | | 91 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千元,每股除外)
|
| |||||||||||||||
淨銷售額
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | |
銷貨成本
|
| | | | 543,472 | | | | | | 563,371 | | | | | | 553,103 | | |
毛利
|
| | | | 256,882 | | | | | | 264,624 | | | | | | 266,879 | | |
銷售、一般和行政費用
|
| | | | 187,688 | | | | | | 181,398 | | | | | | 167,953 | | |
營業收入
|
| | | | 69,194 | | | | | | 83,226 | | | | | | 98,926 | | |
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | |
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | |
所得税前收入
|
| | | | 55,512 | | | | | | 71,505 | | | | | | 88,070 | | |
所得税撥備
|
| | | | 21,960 | | | | | | 16,792 | | | | | | 23,187 | | |
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | |
稀釋
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | |
加權平均已發行普通股 | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | | 40,454 | | | | | | 40,412 | | | | | | 40,181 | | |
稀釋
|
| | | | 40,504 | | | | | | 40,523 | | | | | | 40,385 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | |
衍生工具公允價值變動
|
| | | | (12,854) | | | | | | (5,580) | | | | | | 2,300 | | |
外幣折算調整
|
| | | | (32,513) | | | | | | (4,127) | | | | | | (23,542) | | |
未確認的養老金淨收益(虧損)
|
| | | | (2,521) | | | | | | (1,837) | | | | | | (154) | | |
(撥備)所得税福利
|
| | | | 3,684 | | | | | | 1,846 | | | | | | 350 | | |
其他綜合收益(虧損)
|
| | | | (44,204) | | | | | | (9,698) | | | | | | (21,046) | | |
綜合收益(虧損)
|
| | | $ | (10,652) | | | | | $ | 45,015 | | | | | $ | 43,837 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
| | |
(以千為單位,共享除外
和每股金額) |
| |||||||||
資產 | | | | | | | | | | | | | |
現金和現金等價物
|
| | | $ | 36,343 | | | | | $ | 57,573 | | |
短期投資
|
| | | | 55,000 | | | | | | 24,000 | | |
應收賬款淨額
|
| | | | 126,522 | | | | | | 159,022 | | |
庫存,淨額
|
| | | | 196,659 | | | | | | 198,322 | | |
其他流動資產
|
| | | | 37,313 | | | | | | 27,245 | | |
流動資產總額
|
| | | | 451,837 | | | | | | 466,162 | | |
物業、廠房和設備,淨額
|
| | | | 148,109 | | | | | | 140,235 | | |
無形資產,淨額
|
| | | | 70,997 | | | | | | 47,478 | | |
商譽
|
| | | | 52,679 | | | | | | 27,348 | | |
其他資產
|
| | | | 60,478 | | | | | | 45,448 | | |
總資產
|
| | | $ | 784,100 | | | | | $ | 726,671 | | |
負債和股東權益 | | | | | | | | | | | | | |
長期債務的當前部分
|
| | | $ | 18,750 | | | | | $ | 12,540 | | |
應付帳款
|
| | | | 66,091 | | | | | | 73,189 | | |
應計費用和其他流動負債
|
| | | | 72,397 | | | | | | 68,498 | | |
流動負債總額
|
| | | | 157,238 | | | | | | 154,227 | | |
循環信貸安排
|
| | | | 169,000 | | | | | | 96,000 | | |
長期債務
|
| | | | 199,257 | | | | | | 217,635 | | |
其他負債
|
| | | | 70,401 | | | | | | 42,794 | | |
總負債
|
| | | | 595,896 | | | | | | 510,656 | | |
承付款和或有事項(附註13) | | | | | | | | | | | | | |
普通股, 面值為每股0.0001美元;3億股A類股
授權,2020年和2019年6月30日發行和發行的20,287,574股; 30,000,000股授權發行的B類股,20,166,034股已發行和已發行股票 2020年6月30日和2019年6月30日 |
| | | | 4 | | | | | | 4 | | |
優先股, 面值每股0.0001美元;授權1600萬股,
未發行和發行任何股票 |
| | | | — | | | | | | — | | |
實收資本
|
| | | | 135,525 | | | | | | 133,266 | | |
留存收益
|
| | | | 183,060 | | | | | | 168,926 | | |
累計其他綜合收益(虧損)
|
| | | | (130,385) | | | | | | (86,181) | | |
股東權益總額
|
| | | | 188,204 | | | | | | 216,015 | | |
總負債和股東權益
|
| | | $ | 784,100 | | | | | $ | 726,671 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
| | |
(千)
|
| |||||||||||||||
經營活動 | | | | | | | | | | | | | | | | | | | |
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | |
將淨收入與經營活動提供(使用)的淨現金進行調整:
|
| | | | | | | | | | | | | | | | | | |
折舊攤銷
|
| | | | 32,341 | | | | | | 27,564 | | | | | | 26,943 | | |
債務發行成本攤銷
|
| | | | 882 | | | | | | 882 | | | | | | 883 | | |
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | |
與收購相關的項目
|
| | | | (2,433) | | | | | | — | | | | | | 3,908 | | |
遞延所得税
|
| | | | 8,125 | | | | | | (105) | | | | | | 6,389 | | |
外幣(收益)虧損,淨額
|
| | | | (2,540) | | | | | | (1,899) | | | | | | (635) | | |
其他
|
| | | | 818 | | | | | | (302) | | | | | | 1,181 | | |
扣除業務收購後的營業資產和負債變動:
|
| | | | | | | | | | | | | | | | | | |
應收賬款淨額
|
| | | | 28,713 | | | | | | (23,679) | | | | | | (11,900) | | |
庫存,淨額
|
| | | | (12,930) | | | | | | (20,982) | | | | | | (24,292) | | |
其他流動資產
|
| | | | (11,137) | | | | | | (7,173) | | | | | | 134 | | |
其他資產
|
| | | | (2,121) | | | | | | (299) | | | | | | (152) | | |
應付帳款
|
| | | | (7,672) | | | | | | 12,092 | | | | | | 2,446 | | |
應計費用和其他負債
|
| | | | (8,509) | | | | | | 4,098 | | | | | | (114) | | |
經營活動提供的淨現金
|
| | | | 59,348 | | | | | | 47,169 | | | | | | 70,008 | | |
投資活動 | | | | | | | | | | | | | | | | | | | |
購買短期投資
|
| | | | (80,000) | | | | | | (34,000) | | | | | | (82,000) | | |
短期投資期限
|
| | | | 49,000 | | | | | | 60,000 | | | | | | 32,000 | | |
資本支出
|
| | | | (34,045) | | | | | | (29,891) | | | | | | (18,548) | | |
業務收購
|
| | | | (54,549) | | | | | | (9,838) | | | | | | (15,000) | | |
其他,淨額
|
| | | | (796) | | | | | | (404) | | | | | | (1,064) | | |
投資活動使用的淨現金
|
| | | | (120,390) | | | | | | (14,133) | | | | | | (84,612) | | |
融資活動 | | | | | | | | | | | | | | | | | | | |
循環信貸借款
|
| | | | 243,000 | | | | | | 213,000 | | | | | | 225,000 | | |
循環信貸償還
|
| | | | (170,000) | | | | | | (187,000) | | | | | | (220,000) | | |
支付長期債務和其他
|
| | | | (12,646) | | | | | | (12,649) | | | | | | (6,401) | | |
應付款收購單簽發
|
| | | | — | | | | | | 3,775 | | | | | | — | | |
應付收購單付款
|
| | | | — | | | | | | (3,775) | | | | | | — | | |
普通股發行收益
|
| | | | — | | | | | | 1,134 | | | | | | 5,699 | | |
支付股息
|
| | | | (19,418) | | | | | | (18,592) | | | | | | (16,073) | | |
融資活動提供(使用)的淨現金
|
| | | | 40,936 | | | | | | (4,107) | | | | | | (11,775) | | |
匯率變動對現金的影響
|
| | | | (1,124) | | | | | | (524) | | | | | | (536) | | |
現金及現金等價物淨增(減)
|
| | | | (21,230) | | | | | | 28,405 | | | | | | (26,915) | | |
期初現金和現金等價物
|
| | | | 57,573 | | | | | | 29,168 | | | | | | 56,083 | | |
期末現金和現金等價物
|
| | | $ | 36,343 | | | | | $ | 57,573 | | | | | $ | 29,168 | | |
補充現金流信息 | | | | | | | | | | | | | | | | | | | |
已支付利息,淨額
|
| | | $ | 11,577 | | | | | $ | 12,250 | | | | | $ | 11,208 | | |
已繳納所得税,淨額
|
| | | | 20,866 | | | | | | 16,215 | | | | | | 15,191 | | |
非現金投融資活動
|
| | | | | | | | | | | | | | | | | | |
物業、廠房和設備
|
| | | | 4,353 | | | | | | 2,890 | | | | | | 8,449 | | |
| | |
股份
常見 庫存 |
| |
常見
庫存 |
| |
首選
庫存 |
| |
實收
大寫 |
| |
保留
收入 |
| |
累計
其他 綜合 收入(虧損) |
| |
合計
|
| |||||||||||||||||||||
截至2017年6月30日
|
| | | | 39,875,968 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 123,840 | | | | | $ | 82,750 | | | | | $ | (55,437) | | | | | $ | 151,157 | | |
綜合收益
(虧損) |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 64,883 | | | | | | (21,046) | | | | | | 43,837 | | |
行使股票期權
|
| | | | 481,740 | | | | | | — | | | | | | — | | | | | | 5,699 | | | | | | — | | | | | | — | | | | | | 5,699 | | |
宣佈的股息(每股0.40美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (16,073) | | | | | | — | | | | | | (16,073) | | |
股票薪酬費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 334 | | | | | | — | | | | | | — | | | | | | 334 | | |
截至2018年6月30日
|
| | | | 40,357,708 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 129,873 | | | | | $ | 131,560 | | | | | $ | (76,483) | | | | | $ | 184,954 | | |
採用新的收入標準
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 1,245 | | | | | | — | | | | | | 1,245 | | |
綜合收益
(虧損) |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 54,713 | | | | | | (9,698) | | | | | | 45,015 | | |
行使股票期權
|
| | | | 95,900 | | | | | | — | | | | | | — | | | | | | 1,134 | | | | | | — | | | | | | — | | | | | | 1,134 | | |
宣佈的股息(每股0.46美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (18,592) | | | | | | — | | | | | | (18,592) | | |
股票薪酬費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,259 | | | | | | — | | | | | | — | | | | | | 2,259 | | |
截至2019年6月30日
|
| | | | 40,453,608 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 133,266 | | | | | $ | 168,926 | | | | | $ | (86,181) | | | | | $ | 216,015 | | |
綜合收益
(虧損) |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 33,552 | | | | | | (44,204) | | | | | | (10,652) | | |
宣佈的股息(每股0.48美元)
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (19,418) | | | | | | — | | | | | | (19,418) | | |
股票薪酬費用
|
| | | | — | | | | | | — | | | | | | — | | | | | | 2,259 | | | | | | — | | | | | | — | | | | | | 2,259 | | |
截至2020年6月30日
|
| | | | 40,453,608 | | | | | $ | 4 | | | | | $ | — | | | | | $ | 135,525 | | | | | $ | 183,060 | | | | | $ | (130,385) | | | | | $ | 188,204 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
淨收入
|
| | | $ | 33,552 | | | | | $ | 54,713 | | | | | $ | 64,883 | | |
加權平均股數 - Basic
|
| | | | 40,454 | | | | | | 40,412 | | | | | | 40,181 | | |
股票期權和限制性股票單位的稀釋效應
|
| | | | 50 | | | | | | 111 | | | | | | 204 | | |
加權平均 - 稀釋股數
|
| | | | 40,504 | | | | | | 40,523 | | | | | | 40,385 | | |
每股淨收益 | | | | | | | | | | | | | | | | | | | |
基礎版
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | |
稀釋
|
| | | $ | 0.83 | | | | | $ | 1.35 | | | | | $ | 1.61 | | |
|
營運資金淨額
|
| | | $ | 2,366 | | |
|
物業、廠房和設備
|
| | | | 2,005 | | |
|
固定的無形資產
|
| | | | 32,400 | | |
|
商譽
|
| | | | 25,331 | | |
|
獲取的淨資產
|
| | | $ | 62,102 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
動物健康 | | | | | | | | | | | | | | | | | | | |
MFA和其他
|
| | | $ | 322,300 | | | | | $ | 350,468 | | | | | $ | 336,666 | | |
營養特產
|
| | | | 129,264 | | | | | | 113,215 | | | | | | 122,978 | | |
疫苗
|
| | | | 75,340 | | | | | | 68,291 | | | | | | 72,083 | | |
總體動物健康
|
| | | $ | 526,904 | | | | | $ | 531,974 | | | | | | 531,727 | | |
礦物質營養
|
| | | | 214,412 | | | | | | 233,782 | | | | | | 234,922 | | |
性能產品
|
| | | | 59,038 | | | | | | 62,239 | | | | | | 53,333 | | |
合計
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
美國
|
| | | $ | 471,938 | | | | | $ | 480,101 | | | | | $ | 490,880 | | |
拉丁美洲和加拿大
|
| | | | 158,939 | | | | | | 152,380 | | | | | | 143,231 | | |
歐洲、中東和非洲
|
| | | | 112,179 | | | | | | 105,365 | | | | | | 110,377 | | |
亞太地區
|
| | | | 57,298 | | | | | | 90,149 | | | | | | 75,494 | | |
合計
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
利息費用淨額 | | | | | | | | | | | | | | | | | | | |
定期貸款
|
| | | $ | 7,751 | | | | | $ | 8,553 | | | | | $ | 8,321 | | |
循環信貸安排
|
| | | | 5,317 | | | | | | 3,748 | | | | | | 2,777 | | |
債務發行成本攤銷
|
| | | | 882 | | | | | | 882 | | | | | | 883 | | |
其他
|
| | | | 663 | | | | | | 494 | | | | | | 1,622 | | |
利息支出
|
| | | | 14,613 | | | | | | 13,677 | | | | | | 13,603 | | |
利息(收入)
|
| | | | (1,757) | | | | | | (1,901) | | | | | | (1,693) | | |
| | | | $ | 12,856 | | | | | $ | 11,776 | | | | | $ | 11,910 | | |
|
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
折舊攤銷 | | | | | | | | | | | | | | | | | | | |
物業、廠房和設備折舊
|
| | | $ | 23,250 | | | | | $ | 21,423 | | | | | $ | 21,044 | | |
無形資產攤銷
|
| | | | 8,869 | | | | | | 6,092 | | | | | | 5,851 | | |
其他資產攤銷
|
| | | | 222 | | | | | | 49 | | | | | | 48 | | |
| | | | $ | 32,341 | | | | | $ | 27,564 | | | | | $ | 26,943 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
研發支出
|
| | | $ | 13,738 | | | | | $ | 12,093 | | | | | $ | 9,998 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
應收賬款淨額 | | | | | | | | | | | | | |
應收貿易賬款
|
| | | $ | 130,462 | | | | | $ | 163,464 | | |
壞賬準備
|
| | | | (3,940) | | | | | | (4,442) | | |
| | | | $ | 126,522 | | | | | $ | 159,022 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
壞賬準備 | | | | | | | | | | | | | | | | | | | |
期初餘額
|
| | | $ | 4,442 | | | | | $ | 6,257 | | | | | $ | 6,428 | | |
壞賬準備
|
| | | | 230 | | | | | | (201) | | | | | | 166 | | |
匯率變動的影響
|
| | | | (304) | | | | | | 38 | | | | | | (215) | | |
壞賬核銷
|
| | | | (428) | | | | | | (1,652) | | | | | | (122) | | |
期末餘額
|
| | | $ | 3,940 | | | | | $ | 4,442 | | | | | $ | 6,257 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
庫存 | | | | | | | | | | | | | |
原材料
|
| | | $ | 73,837 | | | | | $ | 64,441 | | |
在製品
|
| | | | 8,881 | | | | | | 10,699 | | |
成品
|
| | | | 113,941 | | | | | | 123,182 | | |
| | | | $ | 196,659 | | | | | $ | 198,322 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
物業、廠房和設備,淨額 | | | | | | | | | | | | | |
土地
|
| | | $ | 9,796 | | | | | $ | 10,152 | | |
建築和改善
|
| | | | 69,444 | | | | | | 71,036 | | |
機械設備
|
| | | | 267,805 | | | | | | 252,097 | | |
| | | | | 347,045 | | | | | | 333,285 | | |
累計折舊
|
| | | | (198,936) | | | | | | (193,050) | | |
| | | | $ | 148,109 | | | | | $ | 140,235 | | |
截至6月30日
|
| |
加權平均
使用壽命 (年) |
| |
2020
|
| |
2019
|
| ||||||
無形資產,淨額 | | | | | | | | | | | | | | | | |
成本 | | | | | | | | | | | | | | | | |
技術
|
| |
12
|
| | | $ | 85,016 | | | | | $ | 71,016 | | |
產品註冊、營銷和分銷權
|
| |
9
|
| | | | 17,795 | | | | | | 17,858 | | |
客户關係
|
| |
12
|
| | | | 31,089 | | | | | | 12,194 | | |
商品名稱、商標和其他
|
| |
5
|
| | | | 3,857 | | | | | | 2,740 | | |
正在進行的研發
|
| | | | | | | — | | | | | | 1,800 | | |
| | | | | | | | 137,757 | | | | | | 105,608 | | |
累計攤銷 | | | | | | | | | | | | | | | | |
技術
|
| | | | | | | (35,859) | | | | | | (29,333) | | |
產品註冊、營銷和分銷權
|
| | | | | | | (17,770) | | | | | | (17,811) | | |
客户關係
|
| | | | | | | (10,336) | | | | | | (8,282) | | |
商品名稱、商標和其他
|
| | | | | | | (2,795) | | | | | | (2,704) | | |
| | | | | | | | (66,760) | | | | | | (58,130) | | |
| | | | | | | $ | 70,997 | | | | | $ | 47,478 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
商譽前滾 | | | | | | | | | | | | | |
期初餘額
|
| | | $ | 27,348 | | | | | $ | 27,348 | | |
收購魚鷹
|
| | | | 25,331 | | | | | | — | | |
期末餘額
|
| | | $ | 52,679 | | | | | $ | 27,348 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
其他資產 | | | | | | | | | | | | | |
ROU經營租賃資產
|
| | | $ | 22,873 | | | | | $ | — | | |
遞延所得税
|
| | | | 11,430 | | | | | | 16,770 | | |
存款
|
| | | | 5,158 | | | | | | 7,024 | | |
保險投資
|
| | | | 5,801 | | | | | | 5,431 | | |
權益法投資
|
| | | | 4,219 | | | | | | 4,196 | | |
賠償資產
|
| | | | 3,000 | | | | | | 3,000 | | |
發債成本
|
| | | | 1,021 | | | | | | 1,531 | | |
其他
|
| | | | 6,976 | | | | | | 7,496 | | |
| | | | $ | 60,478 | | | | | $ | 45,448 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
應計費用和其他流動負債 | | | | | | | | | | | | | |
員工相關
|
| | | $ | 25,825 | | | | | $ | 28,298 | | |
當期經營租賃負債
|
| | | | 6,439 | | | | | | — | | |
佣金和返點
|
| | | | 5,782 | | | | | | 8,397 | | |
專業費
|
| | | | 5,766 | | | | | | 5,212 | | |
所得税和其他税
|
| | | | 3,821 | | | | | | 6,067 | | |
重組成本
|
| | | | 2,314 | | | | | | 3,590 | | |
保險相關
|
| | | | 1,272 | | | | | | 1,279 | | |
衍生品
|
| | | | 5,757 | | | | | | — | | |
其他
|
| | | | 15,421 | | | | | | 15,655 | | |
| | | | $ | 72,397 | | | | | $ | 68,498 | | |
|
2019年6月30日負債餘額
|
| | | $ | 5,590 | | |
|
手續費
|
| | | | 425 | | |
|
付款
|
| | | | (3,155) | | |
|
2020年6月30日負債餘額
|
| | | $ | 2,860 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
其他負債 | | | | | | | | | | | | | |
長期經營租賃負債
|
| | | $ | 17,276 | | | | | $ | — | | |
長期遞延所得税
|
| | | | 11,680 | | | | | | 8,978 | | |
衍生品
|
| | | | 7,691 | | | | | | 977 | | |
補充退休福利、遞延補償和其他
|
| | | | 8,067 | | | | | | 7,605 | | |
或有對價
|
| | | | 4,840 | | | | | | — | | |
國際退休計劃
|
| | | | 5,499 | | | | | | 5,133 | | |
重組成本
|
| | | | 546 | | | | | | 2,000 | | |
美國養老金計劃
|
| | | | 3,563 | | | | | | 3,934 | | |
其他長期負債
|
| | | | 11,239 | | | | | | 14,167 | | |
| | | | $ | 70,401 | | | | | $ | 42,794 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
累計其他綜合收益(虧損) | | | | | | | | | | | | | |
衍生工具
|
| | | $ | (13,448) | | | | | $ | (594) | | |
外幣折算調整
|
| | | | (103,738) | | | | | | (71,225) | | |
未確認的養老金淨收益(虧損)
|
| | | | (22,571) | | | | | | (20,050) | | |
(撥備)衍生工具所得税優惠
|
| | | | 3,256 | | | | | | 148 | | |
(撥備)長期公司間投資所得税優惠
|
| | | | 8,166 | | | | | | 8,166 | | |
(撥備)養老金收益(虧損)所得税收益
|
| | | | (2,050) | | | | | | (2,626) | | |
| | | | $ | (130,385) | | | | | $ | (86,181) | | |
截至6月
|
| |
2020
|
| |
2019
|
| ||||||
2022年6月到期的A期貸款
|
| | | $ | 218,750 | | | | | $ | 231,250 | | |
其他
|
| | | | — | | | | | | 40 | | |
| | | | | 218,750 | | | | | | 231,290 | | |
未攤銷債務發行成本
|
| | | | (743) | | | | | | (1,115) | | |
| | | | | 218,007 | | | | | | 230,175 | | |
少:當前期限
|
| | | | (18,750) | | | | | | (12,540) | | |
| | | | $ | 199,257 | | | | | $ | 217,635 | | |
截至2019年6月30日的年度
|
| | | | | | |
2021
|
| | | | 18,750 | | |
2022
|
| | | | 200,000 | | |
合計
|
| | | $ | 218,750 | | |
截至6月30日
|
| |
2020
|
| |
資產負債表分類
|
| |||
資產: | | | | | | | | | | |
經營租賃ROU資產
|
| | | $ | 22,873 | | | | 其他資產 | |
負債: | | | | | | | | | | |
當前部分
|
| | | | 6,439 | | | |
應計費用和其他流動負債
|
|
非當前部分
|
| | | | 17,276 | | | | 其他負債 | |
營業租賃總負債
|
| | | $ | 23,715 | | | | | |
截至2019年6月30日的年度
|
| |
2020
|
| |||
經營租賃費用
|
| | | $ | 7,570 | | |
可變租賃費用
|
| | | | 1,304 | | |
短期租賃費
|
| | | | 802 | | |
租賃總費用
|
| | | $ | 9,676 | | |
|
截至2019年6月30日的年度
|
| |
2020
|
| |||
用於ROU運營租賃的運營現金流
|
| | | $ | 7,696 | | |
以新的經營租賃負債換取的使用權資產
|
| | | $ | 11,017 | | |
截至
|
| |
2020年6月30日
|
| |||
加權平均剩餘租賃年限(以年為單位) - 淨收益運營租賃
|
| | | | 6.49 | | |
加權平均貼現率 - 淨收益經營租賃
|
| | | | 4.40% | | |
截至6月30日的年度
|
| | |||||
2021
|
| | | $ | 7,211 | | |
2022
|
| | | | 5,634 | | |
2023
|
| | | | 3,308 | | |
2024
|
| | | | 2,659 | | |
2025
|
| | | | 1,798 | | |
2026及以後
|
| | | | 6,869 | | |
租賃支付總額
|
| | | | 27,479 | | |
少:利息
|
| | | | 3,764 | | |
營業租賃總負債
|
| | | $ | 23,715 | | |
截至2019年6月30日的年度
|
| | | | | | |
2020
|
| | | $ | 5,815 | | |
2021
|
| | | | 4,160 | | |
2022
|
| | | | 3,191 | | |
2023
|
| | | | 1,445 | | |
2024
|
| | | | 865 | | |
此後
|
| | | | 765 | | |
最低租金總額
|
| | | $ | 16,241 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| | | | | | | |
2020
|
| |
2019
|
| ||||||||||||
| | |
授權共享
|
| |
面值
|
| |
已發行和流通股
|
| |||||||||||||||||||||
優先股
|
| | | | 16,000,000 | | | | | | 16,000,000 | | | | | $ | 0.0001 | | | | | | — | | | | | | — | | |
普通股 - A類
|
| | | | 300,000,000 | | | | | | 300,000,000 | | | | | $ | 0.0001 | | | | | | 20,287,574 | | | | | | 20,287,574 | | |
普通股 - B類
|
| | | | 30,000,000 | | | | | | 30,000,000 | | | | | $ | 0.0001 | | | | | | 20,166,034 | | | | | | 20,166,034 | | |
| | |
RSU
|
| |
授予日期
公允價值 每個RSU共享 |
| |
授予日期
公允價值 |
| |||||||||
2018年5月授予的基於性能的RSU
|
| | | | 200,000 | | | | | $ | 19.63 | | | | | $ | 3,926 | | |
2018年5月批准的基於時間的RSU
|
| | | | 50,000 | | | | | $ | 41.10 | | | | | $ | 2,055 | | |
出色的2020年6月30日和2019年6月
|
| | | | 250,000 | | | | | $ | 23.92 | | | | | $ | 5,981 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| ||||||
預計福利義務變更 | | | | | | | | | | | | | |
年初預計福利義務
|
| | | $ | 68,527 | | | | | $ | 61,557 | | |
利息成本
|
| | | | 2,112 | | | | | | 2,407 | | |
已支付福利
|
| | | | (2,000) | | | | | | (1,758) | | |
精算損失
|
| | | | 10,714 | | | | | | 6,321 | | |
年底預計福利義務
|
| | | $ | 79,353 | | | | | $ | 68,527 | | |
|
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| ||||||
計劃資產變更 | | | | | | | | | | | | | |
年初計劃資產公允價值
|
| | | $ | 64,593 | | | | | $ | 58,648 | | |
計劃資產實際收益率
|
| | | | 10,821 | | | | | | 6,861 | | |
僱主繳費
|
| | | | 2,377 | | | | | | 842 | | |
已支付福利
|
| | | | (2,000) | | | | | | (1,758) | | |
年末計劃資產公允價值
|
| | | $ | 75,791 | | | | | $ | 64,593 | | |
年底資金狀況
|
| | | $ | (3,562) | | | | | $ | (3,934) | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| ||||||
與養老金計劃相關的累計其他綜合收益(虧損) | | | | | | | | | | | | | |
期初餘額
|
| | | $ | (20,050) | | | | | $ | (18,213) | | |
精算淨損失和前期服務費用攤銷
|
| | | | 515 | | | | | | 465 | | |
本期淨精算(虧損)
|
| | | | (3,036) | | | | | | (2,302) | | |
淨變化
|
| | | | (2,521) | | | | | | (1,837) | | |
期末餘額
|
| | | $ | (22,571) | | | | | $ | (20,050) | | |
|
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
福利義務利息成本
|
| | | $ | 2,112 | | | | | $ | 2,407 | | | | | $ | 2,157 | | |
計劃資產預期回報率
|
| | | | (3,144) | | | | | | (2,842) | | | | | | (3,236) | | |
精算淨損失和前期服務費用攤銷
|
| | | | 515 | | | | | | 465 | | | | | | 453 | | |
定期養老金淨支出(收入)
|
| | | $ | (517) | | | | | $ | 30 | | | | | $ | (626) | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
利息成本貼現率
|
| | | | 2.2% | | | | | | 3.1% | | | | | | 3.9% | | |
計劃資產預期收益率
|
| | | | 4.9% | | | | | | 4.9% | | | | | | 5.6% | | |
年終福利債務貼現率
|
| | | | 2.8% | | | | | | 3.6% | | | | | | 4.2% | | |
截至2019年6月30日的年度
|
| | | | | | |
2021
|
| | | $ | 2,887 | | |
2022
|
| | | | 3,138 | | |
2023
|
| | | | 3,364 | | |
2024
|
| | | | 3,531 | | |
2025
|
| | | | 3,661 | | |
2026 – 2030
|
| | | | 19,789 | | |
| | |
目標
分配 |
| |
百分比
規劃資產 |
| |||||||||
截至2019年6月30日的年度
|
| |
2021
|
| |
2020
|
| |
2019
|
| ||||||
債務證券
|
| |
57% – 77%
|
| | | | 66% | | | | | | 67% | | |
股權證券
|
| |
18% – 38%
|
| | | | 27% | | | | | | 28% | | |
全球資產配置/風險平價(1)
|
| |
0% – 15%
|
| | | | 5% | | | | | | 4% | | |
其他
|
| |
0% – 10%
|
| | | | 2% | | | | | | 1% | | |
| | |
使用
計量公允價值
|
| |||||||||||||||||||||
截至2020年6月30日
|
| |
一級
|
| |
二級
|
| |
第三級
|
| |
合計
|
| ||||||||||||
現金和現金等價物
|
| | | $ | 1,812 | | | | | $ | — | | | | | $ | — | | | | | $ | 1,812 | | |
共同-集體資金 | | | | | | | | | | | | | | | | | | | | | | | | | |
全球大盤股
|
| | | | — | | | | | | 16,678 | | | | | | 4,038 | | | | | | 20,716 | | |
固定收益證券
|
| | | | — | | | | | | 49,902 | | | | | | — | | | | | | 49,902 | | |
全球資產配置/風險平價
|
| | | | — | | | | | | 1,667 | | | | | | — | | | | | | 1,667 | | |
其他 | | | | | | | | | | | | | | | | | | | | | | | | | |
全球資產配置/風險平價
|
| | | | — | | | | | | — | | | | | | 1,669 | | | | | | 1,669 | | |
其他
|
| | | | — | | | | | | — | | | | | | 25 | | | | | | 25 | | |
| | | | $ | 1,812 | | | | | $ | 68,247 | | | | | $ | 5,732 | | | | | $ | 75,791 | | |
|
| | |
使用
計量公允價值
|
| |||||||||||||||||||||
截至2019年6月30日
|
| |
一級
|
| |
二級
|
| |
第三級
|
| |
合計
|
| ||||||||||||
現金和現金等價物
|
| | | $ | 215 | | | | | $ | — | | | | | $ | — | | | | | $ | 215 | | |
共同-集體資金 | | | | | | | | | | | | | | | | | | | | | | | | | |
全球大盤股
|
| | | | — | | | | | | 13,995 | | | | | | 4,016 | | | | | | 18,011 | | |
固定收益證券
|
| | | | — | | | | | | 43,288 | | | | | | — | | | | | | 43,288 | | |
全球資產配置/風險平價
|
| | | | — | | | | | | 1,446 | | | | | | — | | | | | | 1,446 | | |
其他 | | | | | | | | | | | | | | | | | | | | | | | | | |
全球資產配置/風險平價
|
| | | | — | | | | | | — | | | | | | 1,447 | | | | | | 1,447 | | |
其他
|
| | | | — | | | | | | — | | | | | | 186 | | | | | | 186 | | |
| | | | $ | 215 | | | | | $ | 58,729 | | | | | $ | 5,649 | | | | | $ | 64,593 | | |
3項資產的公允價值水平變動
|
| |
2020
|
| |
2019
|
| ||||||
期初餘額
|
| | | $ | 5,649 | | | | | $ | 6,960 | | |
贖回
|
| | | | (49) | | | | | | (4,336) | | |
購買
|
| | | | 200 | | | | | | 2,800 | | |
公允價值變動
|
| | | | (68) | | | | | | 225 | | |
期末餘額
|
| | | $ | 5,732 | | | | | $ | 5,649 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
國內
|
| | | $ | (3,142) | | | | | $ | 2,331 | | | | | $ | 19,819 | | |
外來
|
| | | | 58,654 | | | | | | 69,174 | | | | | | 68,251 | | |
所得税前收入
|
| | | $ | 55,512 | | | | | $ | 71,505 | | | | | $ | 88,070 | | |
|
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
當前撥備(福利): | | | | | | | | | | | | | | | | | | | |
聯邦政府
|
| | | $ | (1,271) | | | | | $ | (459) | | | | | $ | 81 | | |
州和地方
|
| | | | 401 | | | | | | 102 | | | | | | 1,744 | | |
外來
|
| | | | 14,705 | | | | | | 16,603 | | | | | | 15,268 | | |
當前撥備總額
|
| | | | 13,835 | | | | | | 16,246 | | | | | | 17,093 | | |
延期撥備(福利): | | | | | | | | | | | | | | | | | | | |
聯邦政府
|
| | | | 5,226 | | | | | | 858 | | | | | | 2,746 | | |
州和地方
|
| | | | 696 | | | | | | 432 | | | | | | 2,156 | | |
外來
|
| | | | 218 | | | | | | (691) | | | | | | 769 | | |
- 國外估值額度變化
|
| | | | 1,985 | | | | | | (53) | | | | | | 423 | | |
遞延撥備(福利)總額
|
| | | | 8,125 | | | | | | 546 | | | | | | 6,094 | | |
所得税撥備
|
| | | $ | 21,960 | | | | | $ | 16,792 | | | | | $ | 23,187 | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
聯邦所得税税率
|
| | | | 21.0% | | | | | | 21.0% | | | | | | 28.1% | | |
扣除聯邦福利後的州税和地方税
|
| | | | 1.7 | | | | | | 0.6 | | | | | | 1.5 | | |
外國所得税税率
|
| | | | 3.6 | | | | | | 4.1 | | | | | | (4.8) | | |
全球無形低税收入
|
| | | | 6.2 | | | | | | 0.8 | | | | | | — | | |
不確定税位的變化
|
| | | | 5.2 | | | | | | (1.0) | | | | | | 1.1 | | |
提高估值免税額
|
| | | | 3.6 | | | | | | — | | | | | | — | | |
確認聯邦和外國税收抵免
|
| | | | (0.9) | | | | | | (2.5) | | | | | | (0.7) | | |
員工股票期權行權
|
| | | | — | | | | | | (0.4) | | | | | | (4.3) | | |
税法強制收取通行費
|
| | | | — | | | | | | (0.5) | | | | | | 0.5 | | |
遞延税項資產減少
|
| | | | — | | | | | | — | | | | | | 3.9 | | |
其他
|
| | | | (0.8) | | | | | | 1.4 | | | | | | 1.0 | | |
實際税率
|
| | | | 39.6% | | | | | | 23.5% | | | | | | 26.3% | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
遞延税金資產: | | | | | | | | | | | | | |
員工相關應計項目
|
| | | $ | 5,703 | | | | | $ | 5,735 | | |
庫存
|
| | | | 726 | | | | | | 4,766 | | |
環境修復
|
| | | | 974 | | | | | | 1,128 | | |
淨營業虧損結轉 - 國內
|
| | | | 1,618 | | | | | | 902 | | |
淨營業虧損結轉 - 境外
|
| | | | 5,221 | | | | | | 3,703 | | |
經營性租賃負債
|
| | | | 5,732 | | | | | | — | | |
其他
|
| | | | 6,340 | | | | | | 6,302 | | |
| | | | | 26,314 | | | | | | 22,536 | | |
估值津貼
|
| | | | (3,403) | | | | | | (808) | | |
| | | | | 22,911 | | | | | | 21,728 | | |
遞延納税義務: | | | | | | | | | | | | | |
物業、廠房設備和無形資產
|
| | | | (6,108) | | | | | | (6,071) | | |
經營租賃ROU資產
|
| | | | (5,657) | | | | | | — | | |
其他
|
| | | | (921) | | | | | | (772) | | |
| | | | | (12,686) | | | | | | (6,843) | | |
遞延税金淨資產
|
| | | $ | 10,225 | | | | | $ | 14,885 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
其他資產
|
| | | $ | 11,430 | | | | | $ | 16,770 | | |
其他負債
|
| | | | (1,205) | | | | | | (1,885) | | |
| | | | $ | 10,225 | | | | | $ | 14,885 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
期初餘額
|
| | | $ | 808 | | | | | $ | 861 | | | | | $ | 438 | | |
所得税撥備
|
| | | | 2,595 | | | | | | (53) | | | | | | 423 | | |
期末餘額
|
| | | $ | 3,403 | | | | | $ | 808 | | | | | $ | 861 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
未確認的税收優惠 - 期初
|
| | | $ | 6,343 | | | | | $ | 7,000 | | | | | $ | 6,553 | | |
税位更改 - 本期
|
| | | | 2,850 | | | | | | 528 | | | | | | 1,749 | | |
税位變動 - 前期,扣除與税務機關的結算
|
| | | | 108 | | | | | | (317) | | | | | | (994) | | |
訴訟時效失效
|
| | | | | | | | | | (1,053) | | | | | | — | | |
翻譯
|
| | | | 206 | | | | | | 185 | | | | | | (308) | | |
未確認的税收優惠 - 期末
|
| | | | 9,507 | | | | | | 6,343 | | | | | | 7,000 | | |
利息和罰金 - 期末
|
| | | | 969 | | | | | | 750 | | | | | | 633 | | |
與不確定税位相關的總負債
|
| | | $ | 10,475 | | | | | $ | 7,093 | | | | | $ | 7,633 | | |
儀器
|
| |
對衝
|
| |
理論上的
金額為 2020年6月30日 |
| |
合併
資產負債表 |
| |
資產(負債)
截至 的公允價值 |
| ||||||||||||
|
06月30日
2020 |
| |
06月30日
2019 |
| ||||||||||||||||||||
選項
|
| |
巴西雷亞爾電話
|
| |
R$120,000
|
| | |
|
(1)
|
| | | | $ | 126 | | | | | $ | 413 | | |
選項
|
| |
巴西雷亞爾看跌期權
|
| |
R$120,000
|
| | |
|
(1)
|
| | | | $ | (3,900) | | | | | $ | (30) | | |
交換
|
| | 利率互換 | | |
$300,000
|
| | |
|
(2)
|
| | | | $ | (9,674) | | | | | $ | (977) | | |
截至2019年6月30日的年度
|
| |
已記錄損益
在OCI中 |
| |
得(損)
在合併中確認 運營報表 |
| |
合併
的語句 運營 行項目合計 |
| |||||||||||||||||||||||||||||||||
儀器
|
| |
對衝
|
| |
2020
|
| |
2019
|
| |
合併
操作説明書 |
| |
2020
|
| |
2019
|
| |
2020
|
| |
2019
|
| ||||||||||||||||||
選項
|
| |
巴西雷亞爾電話
|
| | | $ | (4,157) | | | | | $ | 475 | | | |
銷貨成本
|
| | | $ | (115) | | | | | $ | 1,069 | | | | | $ | 543,472 | | | | | $ | 563,371 | | |
交換
|
| | 利率互換 | | | | $ | (8,697) | | | | | $ | (6,055) | | | |
利息費用淨額
|
| | | $ | (310) | | | | | $ | 766 | | | | | $ | 12,856 | | | | | $ | 11,776 | | |
| | |
2020
|
| |
2019
|
| ||||||||||||||||||||||||||||||
截至6月30日
|
| |
一級
|
| |
二級
|
| |
第三級
|
| |
一級
|
| |
二級
|
| |
第三級
|
| ||||||||||||||||||
短期投資
|
| | | $ | 55,000 | | | | | $ | — | | | | | $ | — | | | | | $ | 24,000 | | | | | $ | — | | | | | $ | — | | |
外幣衍生品
|
| | | $ | — | | | | | $ | (3,774) | | | | | $ | — | | | | | $ | — | | | | | $ | 383 | | | | | $ | — | | |
利率互換
|
| | | $ | — | | | | | $ | (9,674) | | | | | $ | — | | | | | $ | — | | | | | $ | (977) | | | | | $ | — | | |
收購的或有對價
|
| | | $ | — | | | | | $ | — | | | | | $ | (4,840) | | | | | $ | — | | | | | $ | — | | | | | $ | — | | |
| | |
06月30日
2020 |
| |||
2019年6月30日的餘額
|
| | | $ | — | | |
收購魚鷹
|
| | | | (7,553) | | |
貨幣時間價值增值
|
| | | | (275) | | |
公允價值調整
|
| | | | 2,988 | | |
2020年6月30日的餘額
|
| | | $ | (4,840) | | |
截至2019年6月30日的年度
|
| |
2020
|
| |
2019
|
| |
2018
|
| |||||||||
淨銷售額 | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 526,904 | | | | | $ | 531,974 | | | | | $ | 531,727 | | |
礦物質營養
|
| | | | 214,412 | | | | | | 233,782 | | | | | | 234,922 | | |
性能產品
|
| | | | 59,038 | | | | | | 62,239 | | | | | | 53,333 | | |
總細分市場
|
| | | $ | 800,354 | | | | | $ | 827,995 | | | | | $ | 819,982 | | |
折舊攤銷 | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 26,287 | | | | | $ | 22,312 | | | | | $ | 21,447 | | |
礦物質營養
|
| | | | 2,522 | | | | | | 2,319 | | | | | | 2,371 | | |
性能產品
|
| | | | 1,860 | | | | | | 1,127 | | | | | | 1,029 | | |
總細分市場
|
| | | $ | 30,669 | | | | | $ | 25,758 | | | | | $ | 24,847 | | |
調整後的EBITDA | | | | | | | | | | | | | | | | | | | |
動物健康
|
| | | $ | 123,106 | | | | | $ | 136,049 | | | | | $ | 141,914 | | |
礦物質營養
|
| | | | 14,678 | | | | | | 15,712 | | | | | | 18,583 | | |
性能產品
|
| | | | 4,534 | | | | | | 4,728 | | | | | | 1,881 | | |
總細分市場
|
| | | $ | 142,318 | | | | | $ | 156,489 | | | | | $ | 162,378 | | |
|
|
所得税前收入與調整後EBITDA的對賬
|
| | | | | | | | | | | | | | | | | | |
|
所得税前收入
|
| | | $ | 55,512 | | | | | $ | 71,505 | | | | | $ | 88,070 | | |
|
利息費用淨額
|
| | | | 12,856 | | | | | | 11,776 | | | | | | 11,910 | | |
|
折舊和攤銷 - 總分部
|
| | | | 30,669 | | | | | | 25,758 | | | | | | 24,847 | | |
|
折舊和攤銷 - 公司
|
| | | | 1,672 | | | | | | 1,806 | | | | | | 2,096 | | |
|
企業成本
|
| | | | 40,178 | | | | | | 38,452 | | | | | | 33,420 | | |
|
重組成本
|
| | | | 425 | | | | | | 6,281 | | | | | | — | | |
|
股票薪酬
|
| | | | 2,259 | | | | | | 2,259 | | | | | | 334 | | |
|
銷售商品的收購相關成本
|
| | | | 280 | | | | | | — | | | | | | 1,671 | | |
|
與收購相關的應計薪酬
|
| | | | — | | | | | | — | | | | | | 1,152 | | |
|
與收購相關的交易成本
|
| | | | 462 | | | | | | 213 | | | | | | 400 | | |
|
與收購相關的其他,淨額
|
| | | | (2,821) | | | | | | — | | | | | | (468) | | |
|
其他,淨額
|
| | | | — | | | | | | (1,506) | | | | | | — | | |
|
外幣(收益)虧損,淨額
|
| | | | 826 | | | | | | (55) | | | | | | (1,054) | | |
|
調整後的EBITDA - 總分部
|
| | | $ | 142,318 | | | | | $ | 156,489 | | | | | $ | 162,378 | | |
|
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
可識別資產 | | | | | | | | | | | | | |
動物健康
|
| | | $ | 560,663 | | | | | $ | 508,864 | | |
礦物質營養
|
| | | | 65,686 | | | | | | 67,662 | | |
性能產品
|
| | | | 31,016 | | | | | | 32,886 | | |
總細分市場
|
| | | | 657,365 | | | | | | 609,412 | | |
企業
|
| | | | 126,735 | | | | | | 117,259 | | |
合計
|
| | | $ | 784,100 | | | | | $ | 726,671 | | |
截至6月30日
|
| |
2020
|
| |
2019
|
| ||||||
物業、廠房和設備,淨額 | | | | | | | | | | | | | |
美國
|
| | | $ | 59,778 | | | | | $ | 55,001 | | |
以色列
|
| | | | 54,041 | | | | | | 52,434 | | |
巴西
|
| | | | 14,771 | | | | | | 19,647 | | |
愛爾蘭
|
| | | | 15,263 | | | | | | 9,409 | | |
其他
|
| | | | 4,256 | | | | | | 3,744 | | |
| | | | $ | 148,109 | | | | | $ | 140,235 | | |
| 展品:2.1* | | | 菲布羅動物健康公司作為買方,Osprey BioTechnics,Inc.作為公司,與Lauren Danielson和Vincent Scuilla作為賣方簽署了截至2019年8月1日的資產購買協議(通過參考菲布羅動物健康公司於2019年4月11日提交的Form 10-Q季度報告的附件21.(文件編號001-36410)合併)。 | |
| 展品3.1 | | | 修改並重新發布的《菲布羅動物保健公司註冊證書》(參考菲布羅動物保健公司2014年5月13日提交的《菲布羅動物保健公司10-Q季度報告附件3.1(文件編號001-36410)》)。 | |
| 展品#3.2 | | | 修改和重新修訂菲布羅動物保健公司章程(通過引用菲布羅動物保健公司2014年5月13日提交的10-Q表格季度報告附件33.2(文件編號001-36410))。 | |
| 展品#4.1 | | | 菲布羅動物健康公司與BFI有限公司的註冊權協議,日期為2014年4月16日(引用菲布羅動物健康公司於2014年3月31日提交的S-1/A表格註冊説明書附件4.9(文件編號333-194467))。 | |
| 展品#4.2 | | | 根據1934年《證券交易法》第12節註冊的證券説明(通過引用菲布羅動物健康公司2019年8月27日提交給美國證券交易委員會的2019年年報表格10-K(文件號:0001-36410)附件4.2中的內容而併入)。 | |
| 展品10.1 | | | 菲布羅動物健康公司、美國銀行、N.A.和每一家貸款人之間於2017年6月29日簽訂的信貸協議(通過引用菲布羅動物健康公司於2017年6月29日提交給美國證券交易委員會的當前8-K報告附件10.1(文件編號001-36410))。 | |
| 展品10.2 | | | 撒瑪利亞地毯有限公司和ABIC生物實驗室有限公司之間於2011年1月26日簽訂的無保護租賃協議(引用菲布羅動物健康公司於2014年3月10日提交的S-1表格註冊聲明的附件10.17(文件第333-194467號))。 | |
| 展品#10.3 | | | 傑克·C·本德海姆和菲布羅動物健康公司之間於2014年3月27日簽訂的僱傭協議(通過引用菲布羅動物健康公司於2014年3月31日提交的S-1/A表格註冊説明書第10.18號文件(文件第333-194467號)合併)。 | |
| 展品10.4 | | | 拉里·L·米勒和菲布羅動物健康公司之間於2008年5月2日發出的聘書,包括截至2008年5月2日的保密和保密、員工發明、競業禁止協議(引用菲布羅動物健康公司於2014年3月10日提交的S-1表格註冊説明書第10.20號附件(文件第333-194467號))。 | |
| 展品10.5 | | | 澄清拉里·L·米勒和菲布羅動物健康公司之間於2009年12月21日發出的就業邀請函修正案(合併內容參考菲布羅動物健康公司於2014年3月10日提交的S-1表格註冊聲明附件10.21(文件編號333-194467))。 | |
| 展品10.6 | | | 拉里·L·米勒(Larry L.Miller)和菲布羅動物健康公司(Phibro Animal Health Corporation)之間於2011年12月15日發出的就業邀請函修正案(合併內容參考菲布羅動物健康公司於2014年3月10日提交的S-1表格註冊説明書第10.22號文件(文件編號333-194467))。 | |
| 展品10.7 | | | 菲布羅動物健康公司2008年獎勵計劃(通過引用菲布羅動物健康公司於2014年3月10提交的S-1表格註冊説明書附件10.23(文件第333-194467號)合併)。 | |
| 展品10.8 | | | 菲布羅動物健康公司管理獎勵計劃(通過引用菲布羅動物健康公司2014年3月31日提交的S-1/A表格註冊説明書附件10.24(文件第333-194467號)併入)。 | |
| 展品10.9 | | | 菲布羅動物健康公司退休收入和遞延補償計劃,截至2009年4月15日修訂並重述(引用菲布羅動物健康公司2014年3月10日提交的S-1表格註冊説明書第10.25號文件(第333-194467號文件))。 | |
| 展品編號10.10 | | | 菲布羅動物健康公司高管收入遞延補償協議,日期為1990年3月1日(引用菲布羅動物健康公司2014年3月10日提交的S-1表格註冊説明書附件10.26(文件編號333-194467))。 | |
| 展品編號10.11 | | | 2009年股票期權授予協議表格(參考菲布羅動物保健公司於2014年3月31日提交的S-1/A表格註冊説明書附件10.28(文件編號333-194467))。 | |
| 展品編號10.12 | | | 2013年股票期權授予協議表格(引用菲布羅動物健康公司於2014年3月31日提交的S-1/A表格註冊説明書附件10.29(文件編號333-194467))。 | |
| 展品#10.13 | | | 賠償協議表格(引用菲布羅動物健康公司2014年4月4日提交的S-1/A表格註冊説明書附件10.32(文件編號333-194467))。 | |
| 展品:10.14* | | | MJ Biologics,Inc.和Phibro Animal Health Corporation之間於2015年1月至20日簽訂的知識產權購買協議(通過引用Phibro Animal Health Corporation於2015年5月11日提交給美國證券交易委員會(Securities And Exchange Commission)的Form 10-Q季度報告附件10.33而併入)。 | |
| 展品:10.15* | | | 截至2015年1月至20日由MJ Biologics,Inc.和菲布羅動物健康公司起草的知識產權購買協議的第一修正案(通過引用菲布羅動物健康公司2018年11月6日提交給美國證券交易委員會的10-Q季度報告附件10.18(文件編號:0001-36410)合併)。 | |
| 展品編號10.16 | | | 限制性股票獎勵協議表格(通過引用菲布羅動物健康公司於2018年5月7日提交給美國證券交易委員會的當前表格T8-K(文件編號13-1840497)附件10.2併入)。 | |
| 展品編號10.17 | | | 菲布羅動物健康公司和理查德·G·約翰遜之間於2015年5月11日簽訂的高管長期激勵協議(通過引用菲布羅動物健康公司2015年年報10-K表的附件10.34併入,於2015年9月10日提交給美國證券交易委員會(文件編號001-36410))。 | |
| 展品編號10.18 | | | Rob Aukerman和Phibro Animal Health Corporation之間於2019年5月6日發出的聘書,包括保密和保密、員工發明以及競業禁止和競業禁止協議。 | |
| 展品編號21.1 | | | 菲布羅動物保健公司子公司列表。 | |
| 展品編號23.1 | | | 獨立註冊會計師事務所同意。 | |
| 展品編號31.1 | | | 首席執行官-根據2002年薩班斯-奧克斯利法案第302節進行認證。 | |
| 展品編號31.2 | | | 首席財務官-根據2002年薩班斯-奧克斯利法案認證 | |
| | | | 第302節。 | |
| 展品32.1** | | | 首席執行官-根據2002年薩班斯-奧克斯利法案第906節進行認證。 | |
| 展品32.2** | | | 首席財務官-根據2002年薩班斯-奧克斯利法案第906節進行認證。 | |
| 展品:101.INS* | | | XBRL實例文檔。 | |
| 展品:101.SCH* | | | XBRL分類擴展架構文檔。 | |
| 展品:101.CAL* | | | XBRL分類擴展計算鏈接庫文檔。 | |
| 展品:101.DEF* | | | XBRL分類擴展定義Linkbase文檔。 | |
| 展品101.LAB* | | | XBRL分類擴展標籤Linkbase文檔。 | |
| 展品:101.PRE* | | | XBRL分類擴展演示文稿Linkbase文檔。 | |
| | | | 菲布羅動物保健公司 | | |||
| 2020年8月26日 | | | 發件人: | | |
/s/Jack C.Bendheim
傑克·C·本德海姆
董事長、總裁兼首席執行官 |
|
| | | | 菲布羅動物保健公司 | | |||
| 2020年8月26日 | | | 發件人: | | |
/s/Jack C.Bendheim
傑克·C·本德海姆
董事長、總裁兼首席執行官 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/理查德·G·約翰遜
理查德·G·約翰遜
首席財務官 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Daniel M.Bendheim
丹尼爾·M·本德海姆
董事兼執行副總裁, 企業戰略 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Jonathan Bendheim
喬納森·本德海姆
麥西地區總監兼總裁和 以色列業務部總經理 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Gerald K.Carlson
傑拉爾德·K·卡爾森
導演 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/E.託馬斯·柯克蘭
E.Thomas Corcoran
導演 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Sam Gejdenon
Sam Gejdenon
導演 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Mary Lou Malanoski
瑪麗·盧·馬拉諾斯基
導演 |
|
| 2020年8月26日 | | | 發件人: | | |
/s/Carol A.Wrenn
卡羅爾·A·雷恩
導演 |
|